<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>00273 Mid Day Module (Pathology-3) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Mid Day Module
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 15425,
    "choices": [
      {
        "id": 61660,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malaria</span></span></p>"
      },
      {
        "id": 61661,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hep B</span></span></p>"
      },
      {
        "id": 61662,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIV </span></span></p>"
      },
      {
        "id": 61663,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dengue </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old individual is scheduled to donate blood for a local blood drive. To ensure the safety of the blood supply, the donor&#39;s blood will be screened for various infectious diseases. Among the following options, which one is typically NOT included in the routine screening for donated blood?</span></span></span></p>",
    "unique_key": "Q4897867",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619970,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Dengue </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Dengue fever is a <strong>viral illness </strong>transmitted by <strong>Aedes mosquitoes. </strong>Unlike some of the other diseases listed, routine screening for Dengue in donated blood is not typically performed. This is because<strong> Dengue is primarily transmitted by mosquitoes rather </strong>than through<strong> blood transfusions.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong> Malaria </strong>is routinely screened for in <strong>donated blood </strong>because it is caused by <strong>parasites transmitted through the bite of infected mosquitoes</strong>. <strong>Screening helps </strong>prevent<strong> </strong>the transmission of<strong> malaria </strong>through <strong>blood transfusions</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">&nbsp; <strong>Hepatitis B </strong>is a<strong> viral infection </strong>that can be transmitted through <strong>blood transfusions. </strong>Screening for <strong>Hepatitis B surface antigen (HBsAg) </strong>is essential to prevent the transmission of the<strong> virus to recipients of donated blood</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong> Screening for HIV </strong>is crucial in <strong>donated blood to prevent the transmission of the virus to recipients</strong>. HIV screening typically involves testing for<strong> antibodies to HIV-1 and HIV-2</strong>, ensuring the<strong> safety of the blood supply</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">While diseases such as <strong>HIV, Hepatitis B, and Malaria </strong>are routinely screened for in <strong>donated blood to ensure the safety of the blood supply</strong>,<strong> Dengue is not </strong>typically included in routine <strong>screening protocols </strong>as it is primarily transmitted by<strong> mosquitoes rather than through blood transfusions</strong>.</span></span></span></span></p>",
    "correct_choice_id": 61663,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15369,
    "choices": [
      {
        "id": 61436,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (9; 22) </span></span></p>"
      },
      {
        "id": 61437,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (15; 17) </span></span></p>"
      },
      {
        "id": 61438,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (8; 14) </span></span></p>"
      },
      {
        "id": 61439,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (8; 21) </span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly male with dragging sensation in abdomen presents in the OPD. His cell count had elevated total leucocyte count and increased platelet count. His peripheral smear shows metamyelocytes, myelocytes, eosinophilia and basophilia (image given for reference). Which of the following is the likely genetic anomaly present in this individual? </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/24/picture7_WdmXOwZ.jpg\" style=\"height:194px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q6747004",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619948,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. t (9; 22)</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> increased cell count (leucocytes and platelets) </strong>with peripheral smear showing <strong>metamyelocytes, myelocytes, eosinophilia and basophilia (mixed myeloid lineage) </strong>is suggestive of a diagnosis of <strong>chronic myeloid leukemia</strong>. Two other features also fit in the diagnosis: </span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age of the patient (peak incidence in 5/6th decade of life) </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The dragging sensation (can be due to splenomegaly seen in CML patients) </span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: t (15;17)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with<strong> acute promyelocytic leukemia (APL).</strong> It involves the fusion of the<strong> PML (promyelocytic</strong> <strong>leukemia) gene on chromosome 15 with the RARA (retinoic acid receptor alpha) gene on chromosome 17</strong>, resulting in the <strong>PML-RARA fusion gene.</strong> This fusion gene plays a crucial role in the pathogenesis of APL.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: t (8;14)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with <strong>Burkitt&#39;s lymphoma.</strong> It involves the<strong> c-MYC gene on chromosome 8 </strong>and the <strong>immunoglobulin</strong> <strong>heavy chain gene on chromosome 14</strong>. The dysregulation of <strong>c-MYC</strong>, a proto-oncogene, contributes to the <strong>rapid and uncontrolled</strong> <strong>proliferation of B cells</strong> in Burkitt&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: t (8;21)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with <strong>acute myeloid leukemia (AML)</strong>, particularly the subtype known as <strong>AML with t(8;21), </strong>also called <strong>AML-M2. </strong>It involves the fusion of the <strong>AML1 (acute myeloid leukemia 1) gene on chromosome 21 with the ETO (eight-twenty-one) gene on chromosome 8, </strong>resulting in the <strong>AML1-ETO fusion gene.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> genetic anomaly </strong>likely present in an <strong>elderly male </strong>with an<strong> elevated leukocyte and platelet count</strong>, peripheral smear showing <strong>metamyelocytes, myelocytes, eosinophilia, and basophilia is t (9;22), </strong>which is associated with <strong>chronic myeloid leukemia (CML).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10th/e p622) </span></span></em></strong></p>",
    "correct_choice_id": 61436,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15394,
    "choices": [
      {
        "id": 61536,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Extrinsic pathway </span></span></span></p>"
      },
      {
        "id": 61537,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Intrinsic pathway </span></span></span></p>"
      },
      {
        "id": 61538,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Platelet function </span></span></span></p>"
      },
      {
        "id": 61539,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Common pathway</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 9-year-old boy with no significant past medical history is brought to the pediatrician by his parents who are concerned about his recent onset of spontaneous bruising and a single episode of nose bleeding that took longer than expected to cease. The child has no known allergies, and there is no family history of bleeding disorders. On physical examination, the paediatrician notes several bruises of varying sizes on his legs and arms, as well as petechiae on his ankles. Initial laboratory tests reveal an elevated prothrombin time (PT) and an elevated activated partial thromboplastin time (aPTT), but a normal platelet count and bleeding time (BT). What is the most likely defect in this child&#39;s coagulation pathway?</span></span></span></span></p>",
    "unique_key": "Q3789526",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619956,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Ans. D) Common pathway</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Defects </strong>in the <strong>common pathway affect factors </strong>that are involved in <strong>both the intrinsic </strong>and <strong>extrinsic pathways </strong>(such as factors X, V, II [prothrombin], and I [fibrinogen]) and would lead to <strong>elevations in both PT and aPTT</strong>, as seen in this patient.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. Extrinsic pathway:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> A defect in the extrinsic pathway would typically <strong>lead to an isolated elevation of PT</strong>, as this pathway is evaluated by the PT test. This does not explain the elevated aPTT observed in the patient.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Intrinsic pathway:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> A defect in the intrinsic pathway would typically <strong>result in an isolated elevation of aPTT</strong>, as this pathway is evaluated by the aPTT test. This also does not explain the elevated PT observed in the patient.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Platelet function:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Platelet function defects usually result in a <strong>prolonged bleeding time </strong>(BT) and <strong>normal coagulation tests </strong>(PT and aPTT). Since the patient has a normal BT, this is unlikely to be the correct diagnosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in the <strong>extrinsic pathway </strong>causes elevation of <strong>PT </strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in the <strong>intrinsic pathway </strong>causes elevation of <strong>aPTT</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defect in <strong>common pathway </strong>cause elevation of <strong>both PT and aPTT</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platelet function defect </span></span></strong><span dir=\"ltr\" lang=\"EN-US\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">causes elevation of <strong>BT</strong>. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Robbins 10<sup>th</sup>/ 120 </span></span></strong></span></span></p>",
    "correct_choice_id": 61539,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15407,
    "choices": [
      {
        "id": 61588,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Febrile non-hemolytic transfusion reaction </span></span></p>"
      },
      {
        "id": 61589,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemolysis</span></span></p>"
      },
      {
        "id": 61590,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transmission of infections </span></span></p>"
      },
      {
        "id": 61591,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Electrolyte imbalance </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common blood transfusion reaction is:</span></span></span></p>",
    "unique_key": "Q3760812",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619965,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A) Febrile non-hemolytic transfusion reaction </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FNHTR is the <strong>most common</strong> type of transfusion reaction. It is characterized by <strong>fever, chills, and rigors without</strong> evidence of <strong>hemolysis. </strong>It is usually caused by a reaction between the<strong> recipient&#39;s immune system and leukocytes </strong>in the transfused blood.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hemolysis: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">it </span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a<strong> serious but less common </strong>transfusion reaction. It occurs when <strong>red blood cells are destroyed, </strong>leading to the release of<strong> hemoglobin into the bloodstream</strong>. Hemolysis can be caused by <strong>various factors, </strong>including <strong>ABO incompatibility, improper storage</strong>, or<strong> bacterial contamination</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Transmission of Infections: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While the transmission of infections is a<strong> serious concern in blood transfusions, </strong>it is <strong>not the most common </strong>transfusion reaction.<strong> Stringent screening and testing procedures for donated blood </strong>have significantly <strong>reduced </strong>the risk of<strong> transmitting infections, </strong>making FNHTR more common.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Electrolyte Imbalance: </strong>Electrolyte imbalances are <strong>not </strong>a common transfusion reaction. However, in some cases, <strong>transfusions with large volumes of blood or specific blood components </strong>can lead to <strong>electrolyte disturbances</strong>. This is <strong>not the primary </strong>or most common transfusion reaction.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Most common<strong> blood transfusion </strong>reaction is <strong><span style=\"color:black\">Febrile non-hemolytic transfusion reaction.</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Robbins 10<sup>th</sup> 667 </span></span></strong></span></span></p>",
    "correct_choice_id": 61588,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14661,
    "choices": [
      {
        "id": 58605,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A biopsy will show a histologic finding of columnar to squamous metaplasia</span></p>"
      },
      {
        "id": 58606,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">It is a known precursor of carcinoma of the stomach</span></p>"
      },
      {
        "id": 58607,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The most common location is the proximal (upper) third of the esophagus</span></p>"
      },
      {
        "id": 58608,
        "text": "<p><span style=\"font-size:12pt;\">It is a known precursor of adenocarcinoma of the esophagus</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 55-year-old male with a chronic history of heartburn and regurgitation undergoes an upper endoscopy. Biopsy of the distal esophagus shows the presence of columnar epithelium with goblet cells. Which of the following is true of Barrett esophagus?</span></p>",
    "unique_key": "Q7742152",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619973,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. D) It is a known precursor of adenocarcinoma of the esophagus</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Barrett esophagus </strong>is a complication of <strong>long-standing gastroesophageal reflux disease </strong>and is a precursor to <strong>esophageal adenocarcinoma</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Barrett esophagus intestinal </strong>is <strong>columnar metaplasia of the esopha\u00acgeal squamous epithelium (squamous\u2013to-columnar). </strong>The columnar epithelium is often of the<strong> intestinal type with goblet cells</strong>. Barrett esophagus is a complication of <strong>long-standing gastroesophageal reflux disease </strong>and is a precursor of <strong>esophageal adenocarcinoma. </strong>The most common location is in the <strong>distal (lower) third of the esophagus</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Option A. Incorrect.&nbsp;</strong>The<strong> biopsy </strong>shows <strong>squamous to columnar metaplasia, </strong>not the other way around.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Option B. Incorrect.</strong>&nbsp;Barrett esophagus is a known precursor of<strong> esophageal adenocarcinoma, </strong>not gastric carcinoma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Option C. Incorrect</strong>. <strong>Barrett esophagus </strong>most commonly occurs in the<strong> distal (lower) third of the esophagus</strong>, not the proximal (upper) third.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\">Barrett esophagus shows intestinal<strong> columnar metaplasia of the esophageal squamous epithelium. </strong>It is a precursor lesion to <strong>esophageal adenocarcinoma</strong>, commonly located in the<strong> distal third of the esophagus.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Important risk factors for esophageal adenocarcinoma include Barrett\u2019s esophagus, GERD, obesity, Tobacco use and radiation exposure.</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 762</strong></span></p>",
    "correct_choice_id": 58608,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15372,
    "choices": [
      {
        "id": 61448,
        "text": "<p><span style=\"font-size:12pt;\">Progenitor B cell</span></p>"
      },
      {
        "id": 61449,
        "text": "<p><span style=\"font-size:12pt;\">Mature B cells</span></p>"
      },
      {
        "id": 61450,
        "text": "<p><span style=\"font-size:12.0pt;\">Na\u00efve B cells</span></p>"
      },
      {
        "id": 61451,
        "text": "<p><span style=\"font-size:12.0pt;\">Germinal centre</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Origin of Chronic Lymphocytic Leukemia/SLL is:</span></p>",
    "unique_key": "Q4434226",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619950,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Na\u00efve B cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ig genes </strong>of some CLL/SLL are somatically <strong>hypermutated, </strong>whereas others are not, suggesting that the <strong>cell of origin</strong> may be either a <strong>post-germinal center memory B cell </strong>or a <strong>naive B cell</strong>. It is <strong>not </strong>originating from<strong> progenitor B cell or mature B cell.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The<strong> cell </strong>of origin for<strong> CLL/SLL is the naive B cell</strong>, which may or may not undergo<strong> somatic hypermutation, </strong>suggesting that <strong>CLL/SLL </strong>can arise from a<strong> pre-germinal center B cell.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10th/e p597)</strong></span></p>",
    "correct_choice_id": 61450,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15362,
    "choices": [
      {
        "id": 61408,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgG</span></span></p>"
      },
      {
        "id": 61409,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgA</span></span></p>"
      },
      {
        "id": 61410,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgD</span></span></p>"
      },
      {
        "id": 61411,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgM</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old male presents with fatigue, weakness, and recurrent infections. Flow cytometry analysis of bone marrow aspirate shows infiltration of small lymphocytes, plasma cells, and lymphoplasmacytoid cells. The patient is diagnosed with lymphoplasmacytoid lymphoma. Which immunoglobulin is most likely to be associated with this lymphoma subtype?</span></span></span></p>",
    "unique_key": "Q2256057",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619945,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) IgM </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lymphoplasmacytoid lymphoma </strong>(or <strong>Waldenstrom&rsquo;s macroglobulinemia) </strong>is a<strong> B cell neoplasm </strong>presenting in 6th or 7th decade of life having features similar to<strong> CLL/ SLL </strong>and <strong>multiple myeloma (MM). </strong>Like MM, there is presence of a <strong>&lsquo;M&rsquo; or monoclonal spike </strong>(caused due to IgM)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>multiple myeloma</strong>, the<strong> M spike </strong>is seen due to<strong> IgG.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (IgG):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While<strong> IgG</strong> is the <strong>most </strong>common <strong>immunoglobulin </strong>produced in <strong>multiple myeloma</strong>, it is not typically associated with lymphoplasmacytoid lymphoma, also known as Waldenstr&ouml;m&rsquo;s macroglobulinemia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: (IgA):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> IgA</strong> is another <strong>immunoglobulin </strong>that can be produced in <strong>multiple myeloma</strong> but is less commonly associated with lymphoplasmacytoid lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (IgD):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>IgD paraproteinemia</strong> is very rare in <strong>plasma cell dyscrasias </strong>and is not commonly seen in lymphoplasmacytoid lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lymphoplasmacytoid lymphoma, </strong>known as <strong>Waldenstr&ouml;m&rsquo;s macroglobulinemia, </strong>is most commonly associated with the overproduction of<strong> monoclonal IgM</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 604) </span></span></em></strong></span></span></p>",
    "correct_choice_id": 61411,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15409,
    "choices": [
      {
        "id": 61596,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Metabolic alkalosis</span></span></span></p>"
      },
      {
        "id": 61597,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Metabolic acidosis </span></span></span></p>"
      },
      {
        "id": 61598,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Respiratory alkalosis </span></span></span></p>"
      },
      {
        "id": 61599,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Respiratory acidosis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 40-year-old male involved in a motor vehicle collision requires a massive transfusion due to severe hemorrhagic shock. He receives 15 units of packed red blood cells within a 24-hour period. </span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which of the following complications is likely to result after several units of blood have been transferred?</span></span></span></span></p>",
    "unique_key": "Q3823748",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619966,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A) Metabolic alkalosis </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Metabolic alkalosis </strong>is a common complication after a <strong>massive transfusion due to the metabolism of citrate,</strong> which is used as an <strong>anticoagulant in stored blood</strong>, into<strong> bicarbonate</strong>.<strong> Lactate</strong>, which may accumulate in <strong>stored blood due to hypoperfusion and anaerobic metabolism</strong>, is also <strong>converted to bicarbonate </strong>when<strong> normal perfusion is restored</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Metabolic acidosis:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> While metabolic acidosis can be present initially <strong>due to hypoperfusion and lactic acidosis</strong>, the administration of several units of blood typically results in the correction of the acidosis, <strong>potentially overshooting into alkalosis </strong>due to the reasons mentioned above.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Respiratory alkalosis:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Respiratory alkalosis typically results from <strong>hyperventilation, </strong>which may occur in patients in<strong> pain or with anxiety</strong>, but it is not directly related to the transfusion of blood products.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. Respiratory acidosis:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Respiratory acidosis is caused by <strong>hypoventilation and the accumulation of carbon dioxide </strong>in the blood. It is not a common complication associated with blood transfusion itself, unless there are<strong> underlying respiratory issues or transfusion-related complications affecting lung function.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Massive Transfusion </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is defined as the need to transfuse from<strong> one to two times the patient&rsquo;s normal blood vol&shy;ume</strong>. In a normal adult, this is equivalent to <strong>10-20 units</strong>. Most common abnormality is <strong>metabolic alkalosis</strong>. It re&shy;sults from conversion of<strong> citrate (present in stored blood) and lactate (accumulated due to hypoperfusion) to bicar&shy;bonate.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Robbins 10<sup>th</sup>/ 668 </span></span></strong></span></span></p>",
    "correct_choice_id": 61596,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14737,
    "choices": [
      {
        "id": 58909,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Crypt hyperplasia</span></p>"
      },
      {
        "id": 58910,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Increase in thickness of the mucosa</span></p>"
      },
      {
        "id": 58911,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Increase in intraepithelial lymphocytes</span></p>"
      },
      {
        "id": 58912,
        "text": "<p><span style=\"font-size:12pt;\">Increase in inflammatory cells in lamina propria</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">A 30-year-old female presents with chronic diarrhea, abdominal pain, and has recently developed a pruritic vesicular rash. Serology tests are positive for anti-tissue transglutaminase antibodies. A biopsy of the small intestine is performed. Which histological finding is least likely to be associated with her probable condition, celiac disease?</span></p>",
    "unique_key": "Q5057623",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619952,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Increased in thickness of the mucosa</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">While there is<strong> crypt hyperplasia </strong>and<strong> increased cell turnover</strong>, the mucosal thickness does not increase in <strong>celiac disease</strong>; instead, there is<strong> villous atrophy </strong>which makes the <strong>mucosa appear flat</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Characteristic <strong>histological features </strong>seen on <strong>duode\u00adnal/ jejunal biopsy in celiac sprue </strong>are:</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Absence or reduced height of villi, </strong>resulting in \u2018<strong>flat</strong>\u2019 appearance.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Crypt cell hyperplasia </strong>compensate for<strong> villous atrophy </strong>and <strong>mucosal thickness remain same</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Increased lymphocytes and plasma cells </strong>in lamina propria.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.&nbsp;Crypt hyperplasia</strong> is seen in <strong>celiac disease </strong>and reflects an effort of the <strong>mucosa to regenerate </strong>despite ongoing damage.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.&nbsp;Increased intraepithelial lymphocytes&nbsp;</strong>are a diagnostic feature of<strong> celiac disease</strong>, often exceeding <strong>25 lymphocytes per 100 enterocytes.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>In celiac disease, the lamina propria&nbsp;</strong>typically shows <strong>increased </strong>numbers of <strong>inflammatory cells</strong>, including <strong>lymphocytes and plasma cells</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In<strong> celiac disease</strong>, despite<strong> crypt hyperplasia compensating for villous atrophy, </strong>the <strong>overall thickness of the mucosa does not increase, </strong>maintaining a '<strong>flat' appearance.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 785</strong></span></p>",
    "correct_choice_id": 58910,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15374,
    "choices": [
      {
        "id": 61456,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Whole body PET CT </span></span></p>"
      },
      {
        "id": 61457,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leucocyte alkaline phosphatase </span></span></p>"
      },
      {
        "id": 61458,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immunophenotyping</span></span></p>"
      },
      {
        "id": 61459,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FISH in the peripheral blood smear </span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A male patient with splenomegaly with myeloid hyperplasia. What&rsquo;s is the next best investigation to be done?</span></span></span></p>",
    "unique_key": "Q2640566",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619951,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. FISH in the peripheral blood smear</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fluorescence in situ hybridization (FISH) </strong>is a <strong>molecular cytogenetic </strong>technique that can be applied to detect <strong>specific genetic abnormalities </strong>and is invaluable for diagnosis of <strong>CML </strong>(more likely from the history given in the question). </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Whole-body<strong> PET CT (Positron Emission Tomography with Computed Tomography) </strong>is a valuable imaging tool, particularly in the evaluation of <strong>lymphomas and solid tumors. </strong>However, it may <strong>not be the first-line investigation for myeloid hyperplasia </strong>or diseases<strong> primarily </strong>involving the <strong>bone marrow.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Leucocyte alkaline phosphatase (LAP) </strong>is an <strong>enzyme </strong>that can be measured <strong>to assess the activity of neutrophils</strong>. <strong>Low LAP </strong>scores may be associated with conditions like<strong> chronic myeloid leukemia (CML). </strong>However, this test alone might not provide a <strong>definitive diagnosis </strong>and is often used in conjunction with other tests.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Immunophenotyping </strong>is a crucial investigation in the context of<strong> hematological disorders</strong>. It involves the analysis of <strong>cell surface markers </strong>on <strong>blood or bone marrow cells </strong>but is more useful for other leukemias like <strong>ALL, AML or CLL. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For a <strong>male </strong>patient with<strong> splenomegaly and myeloid hyperplasia</strong>, the next best investigation is <strong>Fluorescence in situ hybridization (FISH) </strong>in the peripheral blood smear, particularly to detect chromosomal abnormalities such as the<strong> Philadelphia chromosome </strong>in <strong>chronic myeloid leukemia (CML).</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10th/e p482) </span></span></em></strong></span></span></span></p>",
    "correct_choice_id": 61459,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13657,
    "choices": [
      {
        "id": 54589,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It involves both alleles of RB at chromosome locus 13q14 </span></span></span></span></p>"
      },
      {
        "id": 54590,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In sporadic cases, both normal RB alleles must undergo somatic mutation in the same retinoblast </span></span></span></span></p>"
      },
      {
        "id": 54591,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial type is inherited as an autosomal recessive trait</span></span></span></span></p>"
      },
      {
        "id": 54592,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In familial cases, children inherit one defective copy of the RB gene and the other copy is normal</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is false about Knudson&#39;s two-hit hypothesis theory on retinoblastoma?</span></span></p>",
    "unique_key": "Q5881570",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619979,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Familial type is inherited as an autosomal recessive trait </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Retinoblastoma<strong> </strong>is inherited as an autosomal dominant trait.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Knudson&#39;s hypothesis</strong>, also known as the <strong>two-hit hypothesis or multiple-hit hypothesis states </strong>that cancer is the result of accumulated<strong> mutations in a cell&#39;s DNA</strong>.</span></span></span></span><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Two mutations </strong>(hits), involving<strong> both alleles of RB at chromosome locus 13q14, </strong>are required to produce<strong> retinoblastoma.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>In sporadic cases</strong>, both normal<strong> RB alleles </strong>must undergo <strong>somatic mutation </strong>in the same retinoblast (two hits).</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;In familial cases, children inherit one<strong> defective copy of the RB gene in the germline (the first hit), </strong>and the other copy is normal.<strong> Retinoblastoma </strong>develops when the<strong> normal RB allele </strong>is <strong>mutated in retinoblasts </strong>as a result of a <strong>spontaneous somatic mutation (the second hit).</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Familial retinoblastoma </strong>is inherited in <strong>an autosomal dominant pattern, </strong>not autosomal recessive. According to<strong> Knudson&#39;s two-hit hypothesis</strong>, a<strong> single inherited mutation </strong>in<strong> one allele of the RB gene </strong>is sufficient to predispose to<strong> retinoblastoma</strong>, but <strong>a second somatic mutation </strong>in the<strong> other allele </strong>must occur for the <strong>cancer to develop</strong>.</span></span></span></span></p>",
    "correct_choice_id": 54591,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15405,
    "choices": [
      {
        "id": 61580,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EDTA</span></span></p>"
      },
      {
        "id": 61581,
        "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heparin</span></span></p>"
      },
      {
        "id": 61582,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Potassium oxalate + sodium fluoride </span></span></p>"
      },
      {
        "id": 61583,
        "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tri Sodium citrate </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">As a primary healthcare worker, you collect blood samples to measure fasting blood glucose levels in a population screening for diabetes. To ensure accurate results, which anticoagulant should be used to prevent glycolysis in the sample during transport to the laboratory</span></span>? </span></span></span></p>",
    "unique_key": "Q6653533",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619964,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. C) Potassium oxalate + sodium fluoride</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Potassium oxalate + sodium fluoride:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Sodium fluoride <strong>inhibits glycolysis </strong>by inhibiting the<strong> enolase enzyme in the glycolytic pathway</strong>, ensuring <strong>glucose levels remain stable</strong> after blood collection. <strong>Potassium oxalate </strong>acts as an <strong>anticoagulant. </strong>This combination is<strong> ideal for glucose estimation in blood samples.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. EDTA:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> <strong>Ethylenediaminetetraacetic acid </strong>(EDTA) is commonly used as an <strong>anticoagulant in hematology </strong>for<strong> complete blood</strong> <strong>count testing </strong>but not for glucose estimation because it does not prevent glycolysis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Heparin:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Heparin is an<strong> anticoagulant </strong>that prevents blood clotting by<strong> inhibiting thrombin </strong>but does not prevent glycolysis, so it is not the best choice for glucose testing.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. Tri Sodium citrate:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Trisodium citrate is used mainly for<strong> coagulation tests </strong>and <strong>does not inhibit glycolysis</strong>, making it unsuitable for glucose estimation.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct quote &lsquo;<strong>enolase enzyme in the glycolysis is inhibited by fluoride</strong>, and when <strong>blood samples </strong>are taken for measurement of <strong>glucose</strong>, it is<strong> collected in tubes </strong>containing<strong> fluoride to inhibit glycolysis.&rsquo;</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Henry&rsquo;s 21<sup>st</sup> /188, Harper 27th/152 </span></span></strong></span></span></p>",
    "correct_choice_id": 61582,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15335,
    "choices": [
      {
        "id": 61300,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated total leukocyte count </span></span></span></p>"
      },
      {
        "id": 61301,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leucocyte alkaline phosphatase </span></span></span></p>"
      },
      {
        "id": 61302,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythrocyte sedimentation rate </span></span></span></p>"
      },
      {
        "id": 61303,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of immature cells</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The difference between leukemia and leukemoid reaction is done by:</span></span></span></p>",
    "unique_key": "Q8514067",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619983,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Leucocyte alkaline phosphatase </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Leukocyte alkaline phosphatase (LAP) </strong>is a marker that can help d<strong>istinguish between chronic myeloid leukemia (CML) and a leukemoid reaction</strong>. In CML,<strong> LAP is typically low, </strong>while in a <strong>leukemoid reaction, it is normal or elevated. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Elevated total leukocyte count:</strong>&nbsp;<strong>Both leukemia and leukemoid reaction </strong>can result in an <strong>elevated total leukocyte count. </strong>However, the specific characteristics of the white blood cells, along with other parameters, help differentiate between the two.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;Erythrocyte sedimentation rate (ESR):&nbsp;</strong>is a<strong> non-specific marker of inflammation </strong>and is not commonly used to differentiate between leukemia and leukemoid reaction. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Presence of immature cells: </strong>The <em>presence</em> of<strong> immature or blast cells </strong>is <strong><em>not helpful</em> </strong>for differentiating between <strong>leukemia from a leukemoid reaction. </strong>The <strong><em>percentage of immature cells</em></strong> is a crucial factor in distinguishing leukemia from a leukemoid reaction.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Leukocyte alkaline phosphatase (LAP) </strong>score helps differentiate between <strong>chronic myeloid leukemia (CML), where it is typically low</strong>, and a<strong> leukemoid reaction, where it is normal or elevated.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 584)</span></span></em></strong></span></span></span></em></strong></p>",
    "correct_choice_id": 61301,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14687,
    "choices": [
      {
        "id": 58709,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Chronic gastritis</span></p>"
      },
      {
        "id": 58710,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Peptic ulcer disease</span></p>"
      },
      {
        "id": 58711,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Gastric carcinoma</span></p>"
      },
      {
        "id": 58712,
        "text": "<p><span style=\"font-size:12.0pt;\">Duodenal adenomas</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The following have strong causal association with H. pylori infection except:</span></p>",
    "unique_key": "Q5688644",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619980,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Duodenal adenomas</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">H. pylori infection is not strongly associated with <strong>duodenal adenomas</strong>, which are benign tumors of the duodenal epithelium.</span></li><li><span style=\"font-size:16px;\"><strong>Duodenal adenomas</strong> are more commonly associated with <strong>familial adenomatous polyposis (FAP) or sporadic mutations rather than H. pylori infection.&nbsp;</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Explanation</u>:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Chronic gastritis:&nbsp;</strong>There is a strong causal association between <strong>H. pylori infection and chronic gastritis</strong>. H. pylori is a major cause of <strong>chronic active gastritis</strong>, characterized by<strong> inflammation of the gastric mucosa.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Peptic ulcer disease:&nbsp;H. pylori infection&nbsp;</strong>is strongly associated with the development of <strong>peptic ulcer disease</strong>, particularly <strong>duodenal ulcers</strong>. <strong>H. pylori colonization&nbsp;</strong>in the <strong>gastric mucosa&nbsp;</strong>can lead to <strong>mucosal damage and ulcer formation.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Gastric carcinoma:</strong>&nbsp;H. pylori infection is considered a major<strong> risk factor&nbsp;</strong>for the development of<strong> gastric carcinoma,&nbsp;</strong>particularly <strong>intestinal-type gastric adenocarcinoma</strong>. <strong>Chronic inflammation and mucosal damage&nbsp;</strong>induced by <strong>H. pylori&nbsp;</strong>contribute to the carcinogenic process.</span></p><p><span style=\"font-size:16px;\">&nbsp;</span></p><p><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Various gastrointestinal&nbsp;</strong>conditions strong causal association with<strong> H. pylori infection,&nbsp;</strong>including <strong>chronic gastritis, peptic ulcer disease, and gastric carcinoma</strong>, but Duodenal adenomas do not have a strong causal association with H. pylori infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Summary:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">H. pylori \u2192 chronic gastritis \u2192 hyperplastic gastric polyps&nbsp;</span></li><li><span style=\"font-size:16px;\">H. pylori \u2192 gastric adenomas/adenocarcinoma (via atrophic gastritis &amp; intestinal metaplasia)&nbsp;</span></li><li><span style=\"font-size:16px;\">H. pylori \u2192 duodenal ulcers&nbsp;</span></li><li><span style=\"font-size:16px;\">H. pylori \u2192 duodenal adenomas&nbsp;(Not causally related)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>H. pylori-Associated Infections and Tumors</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-05%20140659.jpg\" width=\"711\" height=\"427\"></strong></span></p><p style=\"text-align:justify;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 774</strong></p>",
    "correct_choice_id": 58712,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14662,
    "choices": [
      {
        "id": 58609,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mallory-Weiss tears </span></span></span></p>"
      },
      {
        "id": 58610,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zenker&rsquo;s diverticulum </span></span></span></p>"
      },
      {
        "id": 58611,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schatzki rings </span></span></span></p>"
      },
      {
        "id": 58612,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Traction diverticula</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient complains of pain in the upper portion of his neck on swallowing. He occasionally regurgitates undigested food shortly after eating. Which of the following is the most likely etiology of his problems? </span></span></p>",
    "unique_key": "Q6848513",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619974,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Zenker&rsquo;s diverticulum </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Zenker&#39;s diverticulum:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">This is a<strong> pharyngoesophageal outpouching </strong>that occurs above the <strong>upper esophageal sphincter at a weak point in the pharyngeal musculature (Killian&#39;s triangle). </strong>It&#39;s called a <strong>&quot;false&quot; diverticulum </strong>because only the <strong>mucosal layer herniates </strong>through the muscle layer. Symptoms can include <strong>dysphagia, regurgitation of undigested food, aspiration, and halitosis</strong>.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">This is the classic presentation of <strong>Zenker&rsquo;s diverticulum, </strong>which is a <strong>false diverticulum </strong>formed by <strong>herniation of the mucosa </strong>at a point of weakness<strong> at the junction of the pharynx and esophagus in the posterior hypopharyn&not;geal wall</strong>. It is also associated with <strong>halitosis</strong>, and if the diverticulum fills completely with<strong> food, it can cause dys&not;phagia or obstruction of the esophagus.</strong></span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. Mallory-Weiss tears:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">These are <strong>longitudinal mucosal lacerations </strong>at the<strong> gastroesophageal junction or gastric cardia</strong>. They often occur after<strong> forceful or prolonged vomiting </strong>and can lead to<strong> hematemesis</strong>. <strong>Alcoholics or individuals with bulimia </strong>are at a higher risk for this condition due to<strong> repeated episodes of vomiting.</strong></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Schatzki rings:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">These are <strong>thin, circumferential, mucosal rings </strong>that occur at the <strong>squamocolumnar junction in the distal esophagus</strong>. They can cause<strong> intermittent dysphagia for solid foods </strong>and are often associated with a<strong> sliding hiatal hernia</strong>.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. Traction diverticula:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">These are<strong> &quot;true&quot; diverticula </strong>involving all layers of the esophageal wall. They are typically located in the <strong>mid-esophagus </strong>and can be caused by <strong>pulling forces from outside the esophagus</strong>, such as from <strong>fibrosis in mediastinal lymph nodes</strong>.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><em><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zenker&rsquo;s diverticulum&nbsp;</span></em></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong><em>false diverticulum&nbsp;</em></strong>formed by <strong>herniation of the mucosa </strong>at a <strong>point of weakness </strong>at the junction of the <strong>pharynx and esophagus in the posterior hypopharyn&shy;geal wall</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th /757</span></strong></span></span></p>",
    "correct_choice_id": 58610,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15404,
    "choices": [
      {
        "id": 61576,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heparin</span></span></p>"
      },
      {
        "id": 61577,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EDTA</span></span></p>"
      },
      {
        "id": 61578,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium oxalate </span></span></p>"
      },
      {
        "id": 61579,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3.2% trisodium citrate </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The anticoagulant of choice for anticoagulation testing:</span></span></span></p>",
    "unique_key": "Q7889064",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619963,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D) 3.2% trisodium citrate </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trisodium citrate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>calcium chelator </strong>and is commonly used as the <strong>anticoagulant of choice for coagulation </strong>testing particularly for tests like<strong> prothrombin time (PT) and activated partial thromboplastin time (APTT)</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Heparin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is an <strong>anticoagulant </strong>that acts by potentiating the<strong> activity of antithrombin III, </strong>thereby <strong>inhibiting thrombin and</strong> <strong>other coagulation factors. </strong>While heparin is commonly <strong>used in clinical settings </strong>for<strong> anticoagulation,</strong> it is <strong>not the anticoagulant of choice for anticoagulation testing, </strong>as it can interfere with clotting assays.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. EDTA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is an <strong>anticoagulant </strong>that <strong>chelates calcium ions</strong>, <strong>preventing the coagulation </strong>process by <strong>inhibiting clotting factors </strong>that depend on<strong> calcium</strong>. EDTA is commonly used for<strong> collecting blood samples for hematology studies, </strong>such as<strong> complete blood counts</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sodium oxalate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> also <strong>chelates calcium ions</strong>, similar to<strong> EDTA</strong>, and is used for collecting blood samples for<strong> glucose testing (enolase acting as a glycolysis inhibitor).</strong></span></span></span></p>\r\n\r\n<p style=\"margin-left:24px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>anticoagulant of choice for anticoagulation </strong>testing is <strong>3.2% trisodium citrate.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Question Id-15404 Unique Key-Q7889064</span></strong></span></span></span></p>",
    "correct_choice_id": 61579,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15351,
    "choices": [
      {
        "id": 61364,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular center lymphoma </span></span></span></p>"
      },
      {
        "id": 61365,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte depleted Hodgkin&rsquo;s disease</span></span></span></p>"
      },
      {
        "id": 61366,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nodular sclerosis Hodgkin&rsquo;s disease</span></span></span></p>"
      },
      {
        "id": 61367,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte predominant Hodgkin&rsquo;s disease</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The lymphocytic and histiocytic variant of Reed- Sternberg cell is seen in:</span></span></span></p>",
    "unique_key": "Q4119184",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619989,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Lymphocyte predominant Hodgkin&rsquo;s disease</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reed-Sternberg cells </strong>are<strong> large, abnormal cells </strong>that are characteristic of<strong> Hodgkin&#39;s lymphoma. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte predominant Hodgkin&rsquo;s disease:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In lymphocyte-predominant Hodgkin&#39;s disease, the<strong> Reed-Sternberg cells </strong>have a <strong>popcorn-like appearance </strong>and are surrounded by a<strong> nodular and infiltrate of lymphocytes.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Follicular center lymphoma:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Reed-Sternberg cells </strong>are <strong>not </strong>typically associated with <strong>follicular center lymphoma</strong>, which is a subtype of <strong>non-Hodgkin&#39;s lymphoma</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the<strong> lymphocyte-depleted subtype of Hodgkin&#39;s disease</strong>, the<strong> Reed-Sternberg cells </strong>are surrounded by a<strong> small number of lymphocytes </strong>and a significant number o<strong>f histiocytes (macrophages). </strong>This variant is associated with a <strong>poorer prognosis </strong>compared to other subtypes of Hodgkin&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Nodular sclerosis Hodgkin&rsquo;s disease:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The nodular sclerosis <strong>subtype of Hodgkin&#39;s disease </strong>typically features <strong>Reed-Sternberg cells with a lacunar (empty) </strong>appearance, surrounded by <strong>fibrous bands.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> lymphocytic and histiocytic (L&amp;H) </strong>variant of<strong> Reed-Sternberg cells</strong>, often called <strong>&quot;popcorn cells,&quot; </strong>is characteristic of lymphocyte <strong>predominant Hodgkin&rsquo;s disease</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> /613</strong></span></span></p>",
    "correct_choice_id": 61367,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14717,
    "choices": [
      {
        "id": 58829,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Infiltration of histiocytes in the lamina propria</span></p>"
      },
      {
        "id": 58830,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Granuloma in the lamina</span></p>"
      },
      {
        "id": 58831,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Macrophages with PAS (+) material inside the lamina propria</span></p>"
      },
      {
        "id": 58832,
        "text": "<p><span style=\"font-size:12pt;\">Eosinophils in the lamina propria</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">A 50-year-old male patient presents with arthralgia, chronic diarrhea, and weight loss. An upper GI endoscopy is performed, and duodenal biopsy samples are obtained. Histological examination of the biopsy will most likely reveal which of the following features consistent with Whipple's disease?</span></p>",
    "unique_key": "Q5605393",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619993,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Macrophages with PAS (+) material inside the lamina propria</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">The presence of<strong> PAS-positive macrophages </strong>in the <strong>lamina propria </strong>containing <strong>small bacilli is a hallmark of Whipple's disease </strong>and helps differentiate it from other gastrointestinal diseases.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Hallmark of Whipple\u2019s disease </strong>had been presence of <strong>PAS positive macrophages </strong>containing the characteristic <strong>small bacilli</strong>.&nbsp; Also know that the presence of<strong> T. Whipplei outside of macrophages is more important </strong>indicator of active disease than is their presence inside the macrophages.</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>Histiocyte infiltration</strong> is a feature seen in many types of <strong>chronic inflammation of the GI tract </strong>and is <strong>not specific </strong>to <strong>Whipple's disease</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B.&nbsp;Granulomas&nbsp;</strong>are a histological finding seen in diseases like <strong>tuberculosis, sarcoidosis and Crohn's disease, </strong>but not typically in Whipple's disease.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Eosinophilic infiltration </strong>is more commonly seen in conditions associated with <strong>allergy, parasitic infection, or certain gastrointestinal disorders </strong>but not typically in Whipple's disease.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">The <strong>histological hallmark of Whipple's disease </strong>is the presence of <strong>PAS-positive macrophages </strong>within the <strong>lamina propria</strong>, which contain the causative organism <strong>Tropheryma whipplei</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 796</strong></span></p>",
    "correct_choice_id": 58831,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15412,
    "choices": [
      {
        "id": 61608,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">RBC corresponding to his red cell group and colloids/ crystalloid </span></span></span></p>"
      },
      {
        "id": 61609,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Whole blood corresponding to his plasma group </span></span></span></p>"
      },
      {
        "id": 61610,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">O positive RBC and colloids/crystalloid </span></span></span></p>"
      },
      {
        "id": 61611,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">AB negative whole blood</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 55 years old male accident victim in casualty urgently needs blood. The blood bank is unable to determine his ABO group, as his red cell group and plasma group do not match. Emergency transfusion of the patient should be with:</span></span></span></span></p>",
    "unique_key": "Q5809961",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619968,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. C) O positive RBC and colloids/crystalloid </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Selection of blood for emergency transfusion </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">If patient&rsquo;s blood group is known, </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">unmatched blood group of the same group may be used. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">If the patient&rsquo;s blood cannot be determined, </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Group O red blood cells </strong>should be chosen. The use of such<strong> unmatched blood should be Rh (&ndash;ve) </strong>when used in woman of child-bearing age in whom we do not want sensitization to Rh antigen. As Rh-negative blood is often in limited supply, <strong>Rh positive blood </strong>is used in the<strong> emergency transfusion of older females and males of unknown blood group</strong>. In such cases <strong>sensitization may occur </strong>but the<strong> risk of an immediate hemolytic reaction is low</strong>. <strong>O blood group </strong>is the <strong>universal donor </strong>and therefore, should be given to this patient. </span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">positive RBCs and colloids/crystalloid:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> In emergencies where the blood type is unknown or cannot be confirmed, it is standard to use <strong>O positive RBCs for males and older females </strong>because of the<strong> availability and lower risk </strong>of causing an <strong>immediate hemolytic reaction</strong>.<strong> Colloids or crystalloids </strong>can be used to<strong> maintain volume</strong>.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. RBCs corresponding to his red cell group and colloids/crystalloid:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> While it might seem intuitive to use RBCs corresponding to his red cell group, in cases where there is a <strong>discrepancy and the patient&#39;s blood group cannot be confirmed, </strong>it is <strong>safer to use group O RBCs, </strong>which are considered <strong>universal donors</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Whole blood corresponding to his plasma group:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> When the ABO group cannot be determined, using whole blood of a specific group is<strong> not recommended </strong>due to the risk of an<strong> ABO incompatibility reaction</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. AB negative whole blood:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> AB negative blood is considered the<strong> universal plasma donor</strong>, <strong>not the universal RBC donor</strong>. This option could result in an<strong> ABO incompatibility reaction if the patient is not AB negative.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>O positive RBCs </strong>can be used in <strong>males and non-childbearing potential females, with colloids or crystalloid solutions </strong>to manage volume, as this approach<strong> minimizes </strong>the risk of<strong> hemolytic transfusion reactions</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Wintrobes 12<sup>th</sup> 836</span></span></strong></span></span></p>",
    "correct_choice_id": 61610,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15336,
    "choices": [
      {
        "id": 61304,
        "text": "<p><span style=\"font-size:12pt;\">Platelet precursors in the bone marrow are normal or elevated</span></p>"
      },
      {
        "id": 61305,
        "text": "<p><span style=\"font-size:12pt;\">Leucocyte precursors in the marrow are normal or elevated</span></p>"
      },
      {
        "id": 61306,
        "text": "<p><span style=\"font-size:12pt;\">Always has hypocellular bone marrow</span></p>"
      },
      {
        "id": 61307,
        "text": "<p><span style=\"font-size:12pt;\">Refractory anemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">In myelodysplastic syndrome, the following statement is incorrect:</span></p>",
    "unique_key": "Q9806708",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619984,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C.&nbsp;Always has hypocellular bone marrow</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Always has hypocellular bone marrow:</strong> This statement is<strong> incorrect.</strong> MDS is often associated with a<strong> hypercellular or normocellular bone marrow </strong>and rarely hypocellular bone marrow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong> <strong>Platelet precursors </strong>in the bone marrow are often <strong>normal or elevated in myelodysplastic syndrome (MDS). </strong>This condition is characterized by <strong>ineffective hematopoiesis</strong>, and it commonly leads to <strong>cytopenias in the peripheral blood</strong>.&nbsp; <strong>Thrombocytopenia </strong>is a common feature in<strong> MDS</strong>, and it contributes to the <strong>increased risk of bleeding </strong>in affected individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B:</strong>&nbsp;<strong>Leucocyte precursors in the bone marrow are normal or elevated:</strong> This statement is correct</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong>&nbsp;<strong>Refractory anemia:</strong> This statement is correct. <strong>Refractory anemia </strong>is a common <strong>subtype of MDS</strong>, characterized by <strong>ineffective erythropoiesis </strong>leading to <strong>anemia </strong>that <strong>does not </strong>respond well to <strong>conventional treatment.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bone marrow in MDS is hypercellular (most commonly) or normocellular (sometimes) or rarely hypocellular</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10<sup>th</sup>/ 620-1)</strong></span></p>",
    "correct_choice_id": 61306,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14660,
    "choices": [
      {
        "id": 58601,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glossitis </span></span></span></p>"
      },
      {
        "id": 58602,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophageal webs </span></span></span></p>"
      },
      {
        "id": 58603,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Megaloblastic anemia </span></span></span></p>"
      },
      {
        "id": 58604,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophageal dysphagia</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 46-year-old female presents with dysphagia, especially with solid foods, and has noted a burning sensation in her tongue. She reports a history of fatigue and breathlessness on exertion. On examination, her tongue is smooth and atrophic, and laboratory tests reveal a microcytic anemia. </span></span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plummer-Vinson syndrome is characterized by all <em>except:</em>&nbsp; </span></span></p>",
    "unique_key": "Q1972617",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619972,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Megaloblastic anemia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Megaloblastic anemia:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Incorrectly </strong>associated. <strong>Plummer-Vinson syndrome</strong> is associated with <strong>iron-deficiency anemia,</strong> not megaloblastic anemia (which is typically due to vitamin B12 or folate deficiency). </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation: </span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Glossitis:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Correctly associated with <strong>Plummer-Vinson syndrome</strong>, representing the<strong> smooth, atrophic tongue </strong>observed in this patient. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Esophageal webs:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Also correctly associated, potentially explaining the <strong>patient&#39;s dysphagia for solids</strong>. </span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Esophageal dysphagia:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Correctly associated, as this symptom is often<strong> due to esophageal webs or strictures </strong>present in <strong>Plummer-Vinson syndrome</strong>.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The clinical features of <strong>Plummer-Vinson syndrome</strong>, include <strong>glossitis, iron-deficiency anemia, and esophageal webs, </strong>and differentiate it from megaloblastic anemia.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plummer-Vinson syndrome,<strong> also known as Paterson-Brown-Kelly syndrome,</strong> is characterized by the triad of<strong> glossitis, iron-deficiency anemia, and esophageal webs</strong>. So, the correct answer is (c) Megaloblastic anemia. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/757</span></strong></span></span></p>",
    "correct_choice_id": 58603,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14663,
    "choices": [
      {
        "id": 58613,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Achalasia</span></p>"
      },
      {
        "id": 58614,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Barrett\u2019s esophagus</span></p>"
      },
      {
        "id": 58615,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hiatal hernia</span></p>"
      },
      {
        "id": 58616,
        "text": "<p><span style=\"font-size:12pt;\">Plummer-Vinson syndrome</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A female with chronic dysphagia undergoes an upper endoscopy that reveals massive dilation of the distal esophagus. The esophagus is kinked and tortuous and partly filled with undigested foods. What is the most likely diagnosis for this patient?</span></p>",
    "unique_key": "Q7957414",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619975,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. A) Achalasia</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Achalasia:</strong>&nbsp;Correct. Achalasia is defined by impaired<strong> esophageal motility and relaxation of the lower esophageal sphincter</strong>, causing <strong>food accumulation and dilation of the esophagus</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Option B. Barrett\u2019s Esophagus:&nbsp;Incorrect for this scenario</strong>. Barrett\u2019s esophagus involves the replacement of the<strong> lower esophageal squamous epithelium with columnar epithelium </strong>and is associated with<strong> chronic GERD</strong>, <strong>not</strong> presenting with significant <strong>dilation and kinking </strong>as described.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Option C. Hiatal Hernia:&nbsp;Incorrect.</strong> A hiatal hernia occurs when a portion of the <strong>stomach protrudes through the diaphragm into the chest cavity</strong>. While it can cause <strong>reflux and </strong>some degree of <strong>dysphagia, </strong>it typically <strong>doesn't </strong>result in the <strong>massive dilation and tortuosity of the esophagus</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Option D. Plummer-Vinson Syndrome:&nbsp;</strong>Incorrect. Plummer-Vinson syndrome is associated with i<strong>ron-deficiency anemia, glossitis, and esophageal webs</strong>. It does not present with the dilation and tortuosity as described in the vignette.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\">Characteristic presentation of <strong>achalasia </strong>includes <strong>chronic dysphagia, dilation, and tortuosity of the esophagus, </strong>often with retained <strong>food material, </strong>which is distinguishable from other conditions such as <strong>Barrett's esophagus</strong>, <strong>hiatal hernia, and Plummer-Vinson syndrome.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Symptoms: Progressive dysphagia to solids and liquids, regurgitation of undigested food, weight loss, sometimes chest pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Imaging (Barium swallow): \u201cBird-beak\u201d appearance</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 757</strong></span></p>",
    "correct_choice_id": 58613,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14691,
    "choices": [
      {
        "id": 58725,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Decreased growth of luminal bacteria</span></p>"
      },
      {
        "id": 58726,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Decreased likelihood of developing gastric carcino\u00adma</span></p>"
      },
      {
        "id": 58727,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Decreased plasma concentration of gastrin</span></p>"
      },
      {
        "id": 58728,
        "text": "<p><span style=\"font-size:12pt;\">Increased production of macrocytic red blood cells</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:#0d0d0d;font-size:12.0pt;\">A 52-year-old woman presents with a several-month history of epigastric pain, which is relieved by eating. She has a past medical history significant for Hashimoto's thyroiditis. On physical examination, she is found to have mild pallor. Laboratory tests reveal a serum vitamin B12 level of 150 pg/mL (normal: 200-900 pg/mL) and a mean corpuscular volume (MCV) of 110 fL (normal: 80-100 fL). An upper endoscopy shows atrophic gastritis. </span><span style=\"font-size:12.0pt;\">Which of the following conditions would mostly likely be associated with chronic gastritis (Type A) resulting from autoimmune destruction of parietal cells?</span></p>",
    "unique_key": "Q7865113",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619982,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Increased production of macrocytic red blood cells</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Autoimmune </strong>destruction of <strong>parietal cells </strong>impairs the production of <strong>intrinsic factor</strong>, which is necessary for the absorption of<strong> vitamin B12 in the ileum</strong>. Vitamin B12 deficiency can result in <strong>megaloblastic anemia, </strong>characterized by the production of <strong>macrocytic (large) red blood cells.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Option A:</strong>&nbsp;<strong>Chronic atrophic gastritis</strong>, especially when <strong>caused by an autoimmune process </strong>that destroys<strong> parietal cells</strong>, leads to <strong>hypochlorhydria or achlorhydria</strong>. This can result in an<strong> increased growth of luminal bacteria</strong>, as the <strong>acidic environment </strong>of the stomach normally serves to<strong> limit bacterial overgrowth</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Option B:</strong>&nbsp;<strong>The risk of gastric carcinoma</strong> is actually <strong>increased </strong>in the setting of <strong>chronic gastritis</strong>, particularly when<strong> atrophy </strong>is involved. The <strong>ongoing inflammation and cellular regeneration </strong>can predispose to malignant transformation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong>Option C:</strong>&nbsp;<strong>In autoimmune gastritis</strong>, the <strong>destruction of parietal cells </strong>typically leads to a <strong>decreased secretion of hydrochloric acid. </strong>This would usually result in a <strong>compensatory increase in plasma gastrin levels </strong>due to <strong>loss of negative feedback.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:black;font-size:12pt;\">In <strong>chronic gastritis type A (autoimmune gastritis</strong>), the destruction of <strong>parietal cells </strong>results in <strong>impaired </strong>production of <strong>intrinsic factor and </strong>subsequent<strong> vitamin B12 deficiency</strong>, leading to <strong>megaloblastic anemia </strong>with <strong>macrocytic red blood cells.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>&nbsp;<u>Ref</u>: Robbins 10<sup>th</sup>/ 769</strong></span></p>",
    "correct_choice_id": 58728,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15347,
    "choices": [
      {
        "id": 61348,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular Lymphoma </span></span></span></p>"
      },
      {
        "id": 61349,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burkitt Lymphoma </span></span></span></p>"
      },
      {
        "id": 61350,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Small lymphocytic lymphoma </span></span></span></p>"
      },
      {
        "id": 61351,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphoplasmacytic lymphoma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which one of the following Non-Hodgkin Lymphomas is aggressive?</span></span></span></p>",
    "unique_key": "Q9274575",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619988,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Burkitt Lymphoma</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Burkitt Lymphoma </strong>is considered an aggressive<strong> Non-Hodgkin Lymphoma. </strong>It is characterized by a high proliferation rate of<strong> rapidly dividing cells </strong>and is often associated with the <strong>translocation involving the MYC gene</strong>. Burkitt Lymphoma can occur in<strong> three main</strong> forms:<strong> endemic, sporadic, and immunodeficiency-associated subtypes. </strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Follicular Lymphoma </strong>is an<strong> indolent (slow-growing) Non-Hodgkin Lymphoma</strong>. It has a <strong>more chronic course </strong>and tends to be<strong> less aggressive </strong>compared to Burkitt Lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Small lymphocytic lymphoma </strong>is a<strong> low-grade, indolent lymphoma </strong>that is related to <strong>chronic lymphocytic leukemia (CLL). </strong>It is characterized by the<strong> proliferation of small mature B-cells.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Lymphoplasmacytic lymphoma </strong>is typically an<strong> indolent lymphoma </strong>characterized by the <strong>infiltration of the bone marrow </strong>and other tissues by<strong> small lymphocytes, plasma cells, and lymphoplasmacytic cells.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Burkitt Lymphoma </strong>is an <strong>aggressive Non-Hodgkin Lymphoma </strong>characterized by a <strong>high proliferation rate </strong>and<strong> MYC gene translocation</strong>. <em>&ldquo;<strong>Burkitt lymphoma </strong>is believed to be the <strong>fastest growing hu&shy;man tumor</strong>&rdquo;</em>&hellip;direct line</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbin 10<sup>th</sup> 598)</span></span></em></strong></span></span></span></span></p>",
    "correct_choice_id": 61349,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15338,
    "choices": [
      {
        "id": 61312,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute lymphoblastic leukemia </span></span></span></p>"
      },
      {
        "id": 61313,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute myelogenous leukemia </span></span></span></p>"
      },
      {
        "id": 61314,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic lymphocytic leukemia </span></span></span></p>"
      },
      {
        "id": 61315,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic myelogenous leukemia </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of the Philadelphia chromosome is associated with a worse prognosis in patients with which of the following diseases?</span></span></span></p>",
    "unique_key": "Q9651393",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619985,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Acute lymphoblastic leukemia </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Acute Lymphoblastic Leukemia, ALL):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In ALL, the presence of the <strong>Philadelphia chromosome</strong>, which involves the <strong>translocation t(9;22) resulting in the BCR-ABL1 fusion gene</strong>, is associated with a<strong> more aggressive disease </strong>course and a <strong>poorer prognosis. </strong>This is because the<strong> BCR-ABL1 fusion protein has increased tyrosine kinase activity</strong>, which drives the <strong>leukemogenesis. </strong>Patients with <strong>Philadelphia chromosome-positive ALL </strong>often require<strong> more </strong>intensive treatment, such as <strong>tyrosine kinase inhibitors (TKIs) </strong>in addition to<strong> chemotherapy</strong>, and may be considered for <strong>stem cell transplantation.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: (Acute Myelogenous Leukemia, AML):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>Philadelphia chromosome</strong> is <strong>not </strong>commonly associated with <strong>AML</strong>. AML has other chromosomal abnormalities that are<strong> more predictive of prognosis</strong>, such as the presence of mutations in genes like<strong> FLT3, NPM1, or alterations like t(15;17) in acute promyelocytic leukemia (APL).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (Chronic Lymphocytic Leukemia, CLL):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> CLL is typically <strong>not</strong> associated with the<strong> Philadelphia chromosome.</strong> CLL has its own prognostic markers, such as<strong> deletions in chromosome 13q, 11q, and trisomy 12</strong>, or the mutation status of <strong>IGHV (immunoglobulin heavy chain variable region genes).</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: (Chronic Myelogenous Leukemia, CML):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> Philadelphia chromosome </strong>is the <strong>hallmark of CML</strong> and is present in the vast majority of cases. The<strong> presence of this chromosome </strong>is part of the diagnostic criteria for <strong>CML </strong>and is <strong>not </strong>considered a<strong> worse prognostic factor </strong>within this disease context. The treatment for CML includes<strong> TKIs</strong>, which target the<strong> BCR-ABL1 protein </strong>resulting from the<strong> Philadelphia chromosome translocation.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of the<strong> Philadelphia chromosome</strong>, a <strong>translocation from the long arm of chromosome 22 to chromosome 9 [t(9;22)], </strong>is associated with a<strong> favorable prognosis </strong>in <strong>chronic myelogenous leukemia but</strong> it associated with an <strong>unfavorable outcome in Acute lymphoblastic leukemia</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 601) </span></span></em></strong></p>",
    "correct_choice_id": 61312,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15339,
    "choices": [
      {
        "id": 61316,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (8:14) </span></span></span></p>"
      },
      {
        "id": 61317,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (9:22) </span></span></span></p>"
      },
      {
        "id": 61318,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (11:14) </span></span></span></p>"
      },
      {
        "id": 61319,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">t (8:21) </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burkitt&rsquo;s lymphoma is associated most commonly with of the following translocations?</span></span></span></p>",
    "unique_key": "Q5327676",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619986,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. t (8:14) </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Burkitt&#39;s lymphoma </strong>is most commonly associated with the<strong> translocation t(8:14). </strong>This translocation involves the<strong> c-MYC gene </strong>on <strong>chromosome 8 and the immunoglobulin heavy chain (IgH) gene on chromosome 14</strong>. The result of this translocation is the dysregulation and constitutive activation of the <strong>c-MYC oncogene</strong>, leading to <strong>uncontrolled cell proliferation </strong>characteristic of<strong> Burkitt&#39;s lymphoma.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: t (9:22)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with <strong>Chronic Myelogenous Leukemia (CML) </strong>and<strong> Acute Lymphoblastic Leukemia (ALL) </strong>but not Burkitt&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: t (11;14)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: is associated with <strong>Mantle Cell Lymphoma </strong>but not Burkitt&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>t (8:21)</strong>: is associated with <strong>Acute Myeloid Leukemia (AML)</strong> with<strong> maturation </strong>but not Burkitt&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Burkitt&#39;s lymphoma </strong>is most commonly associated with the <strong>translocation t(8;14)</strong>, involving the<strong> c-MYC gene on chromosome 8 and</strong> the <strong>immunoglobulin heavy chain gene on chromosome 14.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 602) </span></span></em></strong></p>",
    "correct_choice_id": 61316,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14712,
    "choices": [
      {
        "id": 58809,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Linitis plastic</span></p>"
      },
      {
        "id": 58810,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Polypoidal growth</span></p>"
      },
      {
        "id": 58811,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Ulcerative</span></p>"
      },
      {
        "id": 58812,
        "text": "<p><span style=\"font-size:12pt;\">Superficial spreading</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 60-year-old patient presents with dyspepsia and an upper gastrointestinal endoscopy reveals a lesion in the stomach. Histopathological examination is consistent with gastric carcinoma. Which type of gastric carcinoma is associated with the best prognosis?</span></p>",
    "unique_key": "Q1473685",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619990,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Ans. D) Superficial spreading</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Superficial spreading gastric carcinoma</strong>, confined to the<strong> mucosal layer</strong>, is likely to have a <strong>more favorable prognosis </strong>because of the potential for<strong> complete surgical removal </strong>and <strong>lower likelihood of metastasis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Option A:</strong>&nbsp;<strong>Linitis plastica</strong> is known for its<strong> poor prognosis </strong>because the<strong> diffuse infiltration </strong>makes it <strong>difficult to completely resect </strong>and <strong>treat effectively.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Option B:</strong>&nbsp;<strong>Polypoidal </strong>growths tend to be<strong> localized </strong>and can often be<strong> respected</strong>, leading to a relatively <strong>better prognosis </strong>compared to <strong>more invasive forms</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Option C:</strong>&nbsp;<strong>Ulcerative </strong>gastric cancers can<strong> vary in prognosis. </strong>If the ulceration is <strong>superficial with minimal invasion</strong>, the prognosis can be <strong>good</strong>, but <strong>deeply invasive ulcerations </strong>are associated with a <strong>poorer outcome</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;font-size:16px;\"><strong>Superficial spreading gastric carcinoma</strong>, which is confined to the<strong> mucosal layer </strong>and <strong>does not invade deeper gastric wall layers</strong>, is associated with the<strong> best prognosis </strong>among the types of <strong>gastric carcinoma listed.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\">Why Superficial Spreading Has the Best Prognosis:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Limited to the mucosa or submucosa (early gastric cancer).</span></li><li><span style=\"font-size:16px;\">Even with wide lateral spread, the depth of invasion is minimal.</span></li><li><span style=\"font-size:16px;\">Often detected early with endoscopic screening (especially in Japan).</span></li><li><span style=\"font-size:16px;\">Excellent 5-year survival rates (&gt;90%) after surgical resection.</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 775</strong></span></p>",
    "correct_choice_id": 58812,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14714,
    "choices": [
      {
        "id": 58817,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Gastrinoma</span></p>"
      },
      {
        "id": 58818,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Insulinoma</span></p>"
      },
      {
        "id": 58819,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Lipoma</span></p>"
      },
      {
        "id": 58820,
        "text": "<p><span style=\"font-size:12pt;\">Glucagonoma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">A 37-year-old woman with a family history of Multiple Endocrine Neoplasia type 1 (MEN I) presents with symptoms of peptic ulcer disease that have not responded to standard treatment. Laboratory tests show elevated serum gastrin levels. Which of the following is the most common functional pancreatic neuroendocrine tumor associated with MEN I in this patient?</span></p>",
    "unique_key": "Q6548522",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619992,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. A) Gastrinoma</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Gastrinomas </strong>are often the <strong>most</strong> common functional <strong>neuroendocrine tumor </strong>in patients with <strong>MEN I </strong>and are directly related to the symptoms described.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Multiple Endocrine Neoplasia type 1 (MEN I) </strong>is characterized by tumors involving the<strong> parathyroid glands, pancreas, and pituitary gland.</strong> <strong>Gastrinomas</strong>, which are<strong> tumors of the pancreas or duodenum </strong>that secrete <strong>gastrin</strong>, are a common functional tumor associated with<strong> MEN I</strong>. These tumors can lead to<strong> Zollinger-Ellison syndrome</strong>, characterized by <strong>gastric acid hypersecretion and peptic ulcers</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Although insulinomas</strong> are seen in <strong>MEN I</strong>, they are<strong> not </strong>as common as <strong>gastrinomas </strong>and typically present with symptoms related to <strong>hypoglycemia, </strong>not peptic ulcer disease.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>Lipomas</strong> are<strong> benign </strong>and not typically functional, meaning they<strong> do not secrete hormones </strong>that lead to the clinical syndromes associated with MEN I.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Glucagonomas</strong> are <strong>rare neuroendocrine tumors </strong>and when present, are associated with a<strong> distinct </strong>set of clinical features that are not described in this patient.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Gastrinomas </strong>are the most common<strong> functional pancreatic neuroendocrine </strong>tumors associated with <strong>MEN I </strong>and often present with <strong>peptic ulcer disease due to gastric acid hypersecretion.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10th /773</strong></span></p>",
    "correct_choice_id": 58817,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15370,
    "choices": [
      {
        "id": 61440,
        "text": "<p><span style=\"font-size:12pt;\">TRALI</span></p>"
      },
      {
        "id": 61441,
        "text": "<p><span style=\"font-size:12pt;\">HLA alloimmunisation</span></p>"
      },
      {
        "id": 61442,
        "text": "<p><span style=\"font-size:12pt;\">Graft versus host disease</span></p>"
      },
      {
        "id": 61443,
        "text": "<p><span style=\"font-size:12pt;\">Immunomodulation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Irradiation of blood prior to transfusion prevents which of the following complications?</span></p>",
    "unique_key": "Q2173974",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619949,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Graft versus host disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>(Graft versus Host Disease - GVHD):</strong> GVHD occurs when <strong>donor T cells attack the recipient's body</strong>. <strong>Irradiation of blood products deactivates these T cells</strong>, thereby <strong>preventing GVHD,</strong> which is especially important in <strong>immunocompromised recipients.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: (TRALI - Transfusion-Related Acute Lung Injury):</strong> TRALI is a serious complication characterized by <strong>acute respiratory distress </strong>following<strong> transfusion. </strong>It is thought to be caused by <strong>donor antibodies against recipient leukocytes</strong>. Irradiation does not prevent TRALI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B: (HLA alloimmunization):</strong> HLA alloimmunization can occur when a<strong> patient develops antibodies against HLA antigens from transfused blood</strong>. While leukoreduction can reduce the risk, irradiation of blood products does not prevent HLA alloimmunization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: (Immunomodulation):</strong> Immunomodulation refers to the<strong> potential immune system </strong>changes in <strong>transfusion recipients,</strong> potentially leading to an increased risk of <strong>postoperative infections </strong>and <strong>malignancy recurrence</strong>. <strong>Irradiation\u2019s </strong>role in preventing <strong>immunomodulation </strong>is not clearly established.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Irradiation of white </strong>and <strong>red blood cells prior </strong>to transfusion is primarily used to<strong> prevent graft versus host disease.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">What happens in Transfusion associated-GVHD?</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Donor T cells attack recipient tissues.</span></li><li><span style=\"font-size:12.0pt;\">Occurs particularly in immunocompromised patients (e.g., post-transplant, chemotherapy).</span></li><li><span style=\"font-size:12.0pt;\">It is often fatal.</span></li><li><span style=\"font-size:12.0pt;\">Irradiation (typically with 25\u201330 Gy gamma rays) prevents T-cell proliferation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>(Ref: Robbins 10th/e p671-2)</strong></span></p>",
    "correct_choice_id": 61442,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13647,
    "choices": [
      {
        "id": 54549,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a proto-oncogene</span></span></span></span></p>"
      },
      {
        "id": 54550,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is involved in DNA repair</span></span></span></span></p>"
      },
      {
        "id": 54551,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a tumor suppressor gene</span></span></span></span></p>"
      },
      {
        "id": 54552,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is not involved in colon cancer</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with a family history of colon cancer. They undergo genetic testing, which reveals a mutation in the APC gene. Which of the following is true about APC? </span></span></p>",
    "unique_key": "Q9021906",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619977,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) It is a tumor suppressor gene</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a tumor suppressor gene.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> APC gene </strong>encodes a <strong>protein </strong>that helps regulate<strong> cell division </strong>and may <strong>prevent cells from growing and dividing too rapidly </strong>or in an <strong>uncontrolled way</strong>. <strong>Mutations in the APC gene </strong>can lead to<strong> unchecked cellular proliferation</strong>, predisposing individuals to <strong>cancer, </strong>particularly<strong> colorectal cancer.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; It is a proto-oncogene.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proto-oncogenes are<strong> normal genes </strong>that can become <strong>oncogenes due to mutations or increased expression</strong>.<strong> Oncogenes </strong>can cause the <strong>cells to grow and proliferate excessively</strong>. The <strong>APC gene</strong>, however, functions as a <strong>tumor suppressor gene, not a proto-oncogene.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It is involved in DNA repair.&nbsp;&nbsp;</span></span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>DNA repair </strong>mechanisms are essential in the <strong>prevention of cancer</strong>, the <strong>APC gene itself is not </strong>primarily involved in<strong> DNA repair processes</strong>. Its <strong>primary function </strong>relates to the<strong> regulation of cell growth and division.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It is not involved in colon cancer.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is<strong> incorrect</strong>. The<strong> APC gene </strong>is implicated in<strong> colon cancer</strong>, as<strong> mutations </strong>in this<strong> gene </strong>are commonly found in <strong>both sporadic and hereditary forms of colorectal cancer</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>APC gene </strong>is a<strong> tumor suppressor gene. </strong>Mutations in the<strong> APC gene </strong>lead to a<strong> loss of function</strong>, resulting in<strong> increased cell proliferation and a higher risk for developing colorectal cancer</strong>.</span></span></span></span></p>",
    "correct_choice_id": 54551,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15427,
    "choices": [
      {
        "id": 61668,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-platelet antibodies </span></span></p>"
      },
      {
        "id": 61669,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bone marrow examination </span></span></p>"
      },
      {
        "id": 61670,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WASP gene study </span></span><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></p>"
      },
      {
        "id": 61671,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platelet function analyzer </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young boy presented with recurrent episodes of melena. The physician also found presence of dermatitis like rashes and multiple petechiae. His platelet count was low but red cell and white blood cell counts were normal. Which of the following is the diagnostic investigation in this case?</span></span></span></p>",
    "unique_key": "Q1645499",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619971,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) WASP gene study</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>WASP gene </strong>study refers to the<strong> genetic analysis of the Wiskott-Aldrich syndrome protein (WASP) gene</strong>. Wiskott-Aldrich syndrome is a <strong>rare X-linked recessive disorder </strong>characterized by <strong>thrombocytopenia, recurrent infections, and eczema</strong>. Given the clinical presentation described in the question, which includes<strong> low platelet count, dermatitis-like rashes, and petechiae, </strong>along with a<strong> young male patient</strong>, the possibility of <strong>Wiskott-Aldrich syndrome is high</strong>. Therefore, genetic analysis of the<strong> WASP gene </strong>is the appropriate <strong>diagnostic investigation </strong>in this case.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture4.jpg\" style=\"height:346px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong>Anti-platelet antibodies</strong> are <strong>antibodies </strong>produced by the immune system<strong> against platelets, </strong>which can result in conditions like<strong> immune thrombocytopenic purpura (ITP</strong>). While it could be considered in cases of thrombocytopenia, the clinical presentation described in the question is <strong>more indicative of a specific underlying genetic disorder</strong> rather than an autoimmune cause.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B.</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong>Bone marrow examination</strong> is a valuable diagnostic tool in cases of<strong> unexplained thrombocytopenia </strong>to assess for <strong>abnormalities in platelet production or destruction</strong>. However, in this case, the clinical presentation and history strongly suggest a <strong>specific genetic disorder </strong>rather than a primary bone marrow disorder.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. <strong>Platelet function analyzers</strong> are used to assess<strong> platelet function </strong>in various <strong>bleeding disorders</strong>. While they may be useful in certain contexts, the clinical presentation described in the question suggests a<strong> genetic disorder </strong>rather than a <strong>primary platelet dysfunction</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The <strong>clinical presentation </strong>described, including<strong> thrombocytopenia, recurrent infections, and eczema</strong>, is suggestive of <strong>Wiskott-Aldrich syndrome</strong>, a <strong>rare X-linked recessive disorder</strong>. Genetic analysis of the<strong> WASP gene </strong>is the <strong>diagnostic investigation of choice </strong>to confirm the<strong> diagnosis.</strong></span></span></span></span></p>",
    "correct_choice_id": 61670,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14711,
    "choices": [
      {
        "id": 58805,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">May have a malignant neoplastic transformation</span></p>"
      },
      {
        "id": 58806,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Ileum is the most common site</span></p>"
      },
      {
        "id": 58807,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Associated with c-KIT mutation</span></p>"
      },
      {
        "id": 58808,
        "text": "<p><span style=\"font-size:12pt;\">Histology shows spindle shaped cells</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">A 45-year-old patient presents with an asymptomatic mass in the upper abdomen found incidentally during a routine health check-up. An endoscopic ultrasound followed by a biopsy confirms the presence of a gastrointestinal stromal tumor (GIST). Which of the following statements regarding GISTs is incorrect?</span></p>",
    "unique_key": "Q2741057",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619953,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Ileum is the most common site</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">The most common site for <strong>GISTs is the stomach, not the ileum</strong>. This statement is false and contrary to the typical presentation of GISTs.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Stomach is the most common site.</strong> &nbsp;These have a<strong> tendency for malignant transformation.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A:</strong>&nbsp;<strong>GISTs </strong>have the potential for<strong> malignant transformation</strong>, which is consistent with their classification as a<strong> neoplastic disorder</strong>, potentially<strong> leading to cancer</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C:&nbsp;</strong>Mutations in the<strong> c-KIT gene</strong> are commonly associated with <strong>GISTs.</strong> These mutations are often pathognomonic and a therapeutic target for treatment.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D:&nbsp;</strong>Histologically, <strong>GISTs</strong> can display<strong> spindle-shaped cells,</strong> but they can also present with other patterns, such as <strong>epithelioid or mixed cell types.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">The most common site for<strong> GISTs is the stomach.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><u>Ref</u><strong>:</strong>&nbsp;<strong>Robbins 10<sup>th</sup>/ 779</strong></span></p>",
    "correct_choice_id": 58806,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15395,
    "choices": [
      {
        "id": 61540,
        "text": "<p><span style=\"font-size:12.0pt;\">Microangiopathic hemolytic anemia</span></p>"
      },
      {
        "id": 61541,
        "text": "<p><span style=\"font-size:12.0pt;\">Thrombocytopenia</span></p>"
      },
      {
        "id": 61542,
        "text": "<p><span style=\"font-size:12.0pt;\">Normal complement level</span></p>"
      },
      {
        "id": 61543,
        "text": "<p><span style=\"font-size:12.0pt;\">Grossly abnormal coagulation tests</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">All are true about thrombotic thrombocytopenic purpura except?</span></p>",
    "unique_key": "Q8046986",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619957,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D) Grossly abnormal coagulation tests</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Thrombotic thrombocytopenic purpura </strong>(TTP) is a <strong>rare blood disorder </strong>characterized by the <strong>formation of microclots </strong>in <strong>small blood vessels throughout the body</strong>, leading to <strong>microangiopathic hemolytic anemia </strong>and <strong>thrombocytopenia</strong>. <strong>TTP </strong>is associated with a <strong>deficiency of ADAMTS13 </strong>(a disintegrin and metalloproteinase), an <strong>enzyme </strong>responsible for <strong>cleaving von Willebrand factor</strong>. TTP doesn't grossly affect the standard coagulation tests. So, the coagulation tests such as PT (prothrombin time) and APTT (activated partial thromboplastin time) are typically normal.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Microangiopathic hemolytic anemia:</strong> <strong>True</strong>. <strong>TTP </strong>is associated with the formation of <strong>microclots that damage red blood cells</strong>, leading to<strong> hemolysis.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Thrombocytopenia:</strong> <strong>True</strong>. <strong>TTP </strong>is characterized by<strong> low platelet counts </strong>due to the formation of <strong>platelet-rich microclots.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Normal complement level:</strong> <strong>True</strong>. Unlike other conditions such as <strong>hemolytic uremic syndrome (HUS), TTP is not </strong>typically associated with<strong> complement activation, </strong>so complement levels are generally<strong> normal</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>TTP doesn't </strong>grossly <strong>affect the standard coagulation tests</strong>. So, the <strong>coagulation tests </strong>such as <strong>PT </strong>(prothrombin time) and <strong>APTT </strong>(activated partial thromboplastin time) are typically <strong>normal</strong>. Direct lines from Robbins\u2026 \u201cIf<strong> coagulation tests </strong>indicate a <strong>major consumption of procoagulants, </strong>the diagnosis of <strong>TTP is doubtful</strong>\u201d.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mnemonic for TTP Clinical Features (Pentad):</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FAT RN</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Fever</span></li><li><span style=\"font-size:12.0pt;\">Anemia (microangiopathic hemolytic)</span></li><li><span style=\"font-size:12.0pt;\">Thrombocytopenia</span></li><li><span style=\"font-size:12.0pt;\">Renal dysfunction (mild to moderate)</span></li><li><span style=\"font-size:12.0pt;\">Neurologic symptoms</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 665</strong></span></p>",
    "correct_choice_id": 61543,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15397,
    "choices": [
      {
        "id": 61548,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic thrombocytopenia purpura (ITP)</span></span></p>"
      },
      {
        "id": 61549,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bernard Soulier syndrome </span></span></p>"
      },
      {
        "id": 61550,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disseminated intravascular coagulation </span></span></p>"
      },
      {
        "id": 61551,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wiskott Aldrich syndrome </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 4-year-old boy is brought to the clinic with a history of recurrent ear infections, easy bruising, and severe eczema. On examination, the child has widespread petechiae and a weeping rash over his arms and legs. Laboratory tests reveal thrombocytopenia with an average platelet volume less than the reference range. The boy&#39;s immunoglobulin levels are also noted to be abnormally low. </span>The presence of small sized platelets on the peripheral smear is characteristic of:</span></span></span></p>",
    "unique_key": "Q2872580",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619958,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D) Wiskott Aldrich syndrome </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Wiskott Aldrich syndrome </span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is characterized by the <strong>triad </strong>of: </span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe eczema </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombocytopenia </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recurrent infections </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><strong>Wiskott-Aldrich syndrome </strong>is characterized by the<strong> triad of eczema, thrombocytopenia (with small platelets), and immunodeficiency, </strong>which corresponds to the clinical presentation of this patient.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. Idiopathic thrombocytopenic purpura [ITP]:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> ITP is characterized by <strong>autoimmune destruction of platelets</strong>, typically leading to<strong> thrombocytopenia with normal-sized platelets </strong>and no associated eczema or immunodeficiency.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Bernard-Soulier syndrome:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> Bernard-Soulier syndrome is a <strong>platelet function disorder </strong>due to a deficiency in<strong> glycoprotein Ib,</strong> the platelet receptor for <strong>von Willebrand factor</strong>. Patients may have <strong>thrombocytopenia </strong>with large platelets and no associated eczema or immunodeficiency.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C. Disseminated intravascular coagulation [DIC]:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> DIC is a secondary condition resulting from another <strong>underlying disease</strong>. It is characterized by widespread <strong>activation of coagulation</strong>, which can lead to the <strong>consumption of platelets and coagulation factors</strong>. Platelet size is typically not affected, and it is not associated with eczema or immunodeficiency.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">The characteristic features of <strong>Wiskott-Aldrich syndrome</strong>, include<strong> thrombocytopenia with small platelets, eczema, and recurrent infections </strong>due to immunodeficiency. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Robbins 10<sup>th</sup>/ 243 </span></span></strong></span></span></p>",
    "correct_choice_id": 61551,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14688,
    "choices": [
      {
        "id": 58713,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mucosa</span></p>"
      },
      {
        "id": 58714,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mucosa and submucosa</span></p>"
      },
      {
        "id": 58715,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Muscularis propria</span></p>"
      },
      {
        "id": 58716,
        "text": "<p><span style=\"font-size:12pt;\">Serosa</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">A 63-year-old male with a history of chronic gastritis presents with weight loss and early satiety. An endoscopy with biopsy is performed, revealing a 2 cm lesion in the antrum of the stomach. Histopathology reports a well-differentiated adenocarcinoma. Additional staining shows the cancer is confined to the gastric wall with no evidence of metastasis. </span><span style=\"font-size:12.0pt;\">In early gastric carcinoma, the malignancy is confined to which of the following layers?&nbsp;</span></p>",
    "unique_key": "Q3245730",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619981,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Mucosa and submucosa</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">Involvement of both the<strong> mucosa and submucosa</strong> suggests a <strong>deeper invasion</strong> than option A but still within the <strong>confines of the</strong> <strong>stomach wall</strong>, representing an <strong>intermediate stage of disease.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A.&nbsp;</strong>If a gastric carcinoma is <strong>confined to the mucosa</strong>, it indicates that the <strong>tumor has not penetrated beyond the innermost layer of the stomach</strong>, which is associated with a <strong>less aggressive disease </strong>and often a more favorable prognosis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C.&nbsp;Penetration into the muscularis propria </strong>denotes a<strong> more advanced local invasion </strong>compared to options A and B, suggesting a<strong> higher risk </strong>of further <strong>spread and a worse prognosis </strong>if <strong>not treated promptly.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Invasion of the serosa</strong>, the<strong> outermost layer of the stomach</strong>, implies that the tumor may be at the stage where it is <strong>capable of spreading beyond the stomach to adjacent structures or through the peritoneal surface</strong>, which would <strong>denote a more advanced and aggressive disease.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">In <strong>early gastric carcinoma, </strong>the malignancy confined to the <strong>mucosa and submucosa </strong>signifies a <strong>depth of invasion </strong>that is <strong>more advanced than the mucosal layer alone</strong>, but <strong>not yet </strong>extending into the <strong>muscularis propria or serosa</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 775</strong></span></p>",
    "correct_choice_id": 58714,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15393,
    "choices": [
      {
        "id": 61532,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal platelet count and normal bleeding time </span></span></p>"
      },
      {
        "id": 61533,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal platelet count and increased bleeding time </span></span></p>"
      },
      {
        "id": 61534,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased platelet count and increased bleeding time</span></span></p>"
      },
      {
        "id": 61535,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal platelet count and decreased bleeding time</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patient with bleeding due to platelet function defects has which of the following features?</span></span></span></p>",
    "unique_key": "Q2549306",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619955,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B) Normal platelet count and increased </span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">bleeding time </span></span></strong><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option is characteristic of <strong>platelet function defects. </strong>Although there is a <strong>normal quantity of platelets </strong>(platelet count), the <strong>quality or function of these platelets is compromised</strong>, which means they don&#39;t work as they should, leading to a prolonged bleeding time</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Platelet function defects </strong>typically result in <strong>impaired platelet aggregation or adhesion</strong>, leading to <strong>increased bleeding time</strong>. However, the <strong>platelet count remains normal </strong>in these conditions because the <strong>number of platelets is adequate</strong>, but their function is compromised. Therefore, the features of bleeding due to platelet function defects include a normal platelet count and an increased bleeding time.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Normal platelet count and normal bleeding time:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option would suggest <strong>no defect in platelet function </strong>or <strong>number</strong>, which would not typically be associated with a bleeding disorder.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Decreased platelet count and increased bleeding time:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This suggests a <strong>quantitative defect of platelets</strong>, such as <strong>thrombocytopenia</strong>, rather than a functional defect. Although patients with thrombocytopenia will also have an increased bleeding time, the platelet count in functional defects remains normal.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Normal platelet count and decreased bleeding time:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>decreased bleeding time </strong>indicates an <strong>efficient clotting process</strong>, which would not align with platelet function defects.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Platelet function defects </strong>present with a <strong>normal platelet count </strong>but <strong>impaired function</strong>, leading to an <strong>increased bleeding time</strong>, whereas <strong>quantitative disorders </strong>would show an <strong>altered platelet count</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Robbins 10<sup>th</sup>/ 655</span></span></strong></span></span></p>",
    "correct_choice_id": 61533,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15364,
    "choices": [
      {
        "id": 61416,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tubular casts </span></span></span></p>"
      },
      {
        "id": 61417,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amyloidosis </span></span></p>"
      },
      {
        "id": 61418,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wire loop lesions </span></span></p>"
      },
      {
        "id": 61419,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal tubular necrosis </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Q34. A 60-year-old male with a known history of multiple myeloma presents with worsening renal function. A renal biopsy is performed to assess the renal involvement. Which of the following findings would be considered atypical or not commonly associated with renal complications of multiple myeloma?</span></span></span></p>",
    "unique_key": "Q5304409",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619946,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Wire loop lesions </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wire loop lesions:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Wire loop lesions, seen on<strong> renal biopsy</strong>, are characteristic of<strong> lupus nephritis,</strong> a renal manifestation of <strong>systemic</strong> <strong>lupus erythematosus (SLE).</strong> This finding is <strong>not </strong>typically associated with <strong>multiple myeloma.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Tubular casts:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These can result from the<strong> precipitation of light chains in the renal tubules</strong>, leading to <strong>cast</strong> formation. This is a common finding in<strong> multiple myeloma-associated renal disease.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Amyloidosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Amyloid deposition in the<strong> kidneys is a known complication of multiple myeloma,</strong> leading to <strong>renal</strong> <strong>impairment.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Renal tubular necrosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Direct infiltration of myeloma cells</strong> into the <strong>renal tubules</strong> can cause<strong> tubular necrosis,</strong> contributing to renal dysfunction. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Wire loop lesions </strong>are<strong> not typically associated with multiple myeloma</strong> and are characteristic of<strong> lupus nephritis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 225) </span></span></em></strong> </span></span></span></p>",
    "correct_choice_id": 61418,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14664,
    "choices": [
      {
        "id": 58617,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">CD34</span></p>"
      },
      {
        "id": 58618,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">CD117</span></p>"
      },
      {
        "id": 58619,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">CD30</span></p>"
      },
      {
        "id": 58620,
        "text": "<p><span style=\"font-size:12pt;\">DOG-1</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">A 50-year-old male with a clinical presentation of gastric outlet obstruction undergoes endoscopic biopsy of a gastric lesion. Histopathology indicates a mesenchymal tumor consistent with a GIST. Immunohistochemistry is crucial for definitive diagnosis. Which of the following markers is most appropriate for confirming the diagnosis of GIST?</span></p>",
    "unique_key": "Q8471943",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619976,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D)&nbsp;DOG-1</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>DOG-1:&nbsp;Discovered on GIST-1 (DOG-1)</strong> is a <strong>highly sensitive and specific marker for GISTs</strong>, used particularly when <strong>CD117 </strong>may be <strong>negative or equivocal.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A. CD34:&nbsp;</strong>While <strong>CD34 </strong>can be expressed in <strong>GISTs, </strong>it is <strong>not as specific </strong>as other markers and can be present in a variety of other soft tissue tumors.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B. CD117:&nbsp;</strong>Also known as<strong> c-KIT, CD117 </strong>is a commonly expressed marker in <strong>GISTs </strong>and is considered a<strong> hallmark of diagnosis</strong>. However, it is not exclusive to GISTs and may require additional confirmation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C. CD30:&nbsp;</strong>This marker is <strong>not </strong>commonly associated with <strong>GISTs </strong>and is <strong>more </strong>typically related to <strong>lymphoid malignancies</strong>, such as <strong>Hodgkin lymphoma and anaplastic large cell lymphoma.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>DOG-1 </strong>is an important<strong> immunohistochemical marker for GISTs, </strong>especially when used alongside or in place of <strong>CD117, </strong>to confirm the diagnosis of<strong> GISTs in a biopsy sample</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/779</strong></span></p>",
    "correct_choice_id": 58620,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15360,
    "choices": [
      {
        "id": 61400,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anemia </span></span></p>"
      },
      {
        "id": 61401,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperviscosity </span></span></p>"
      },
      {
        "id": 61402,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bone pains </span></span></span></p>"
      },
      {
        "id": 61403,
        "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infection </span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the least common presentation of multiple myeloma?</span></span></span></p>",
    "unique_key": "Q7523497",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619944,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Hyperviscosity </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Hyperviscosity):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hyperviscosity syndrome is<strong> less commonly </strong>a presenting feature of <strong>multiple myeloma.</strong> It results from the <strong>high</strong> <strong>protein </strong>content in the blood due to excessive production of<strong> monoclonal proteins by myeloma cells,</strong> but not all patients will experience this.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: (Anemia):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Anemia is a common </strong>finding in multiple myeloma, <strong>typically normocytic and normochromic,</strong> caused by the replacement of <strong>bone marrow with myeloma cells</strong>, which impairs normal blood cell production.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: (Bone Pains):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Bone pain, </strong>particularly in the <strong>back or chest</strong>, is a <strong>very common</strong> symptom of multiple myeloma. It results from <strong>bone destruction </strong>due to the<strong> infiltration and activation of osteoclasts by myeloma cells,</strong> leading to lytic lesions or fractures.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: (Infection):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Patients with multiple myeloma have an<strong> increased risk of infections due to an impaired immune response</strong>, both from the disease itself and as a consequence of treatment, making infection a common presentation.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hyperviscosity</strong> is the<strong> least common</strong> presentation of<strong> multiple myeloma compared to anemia, bone pains, and infection.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup>/ 609)</span></em></strong></span></span></p>",
    "correct_choice_id": 61401,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15410,
    "choices": [
      {
        "id": 61600,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Fresh frozen plasma </span></span></span></p>"
      },
      {
        "id": 61601,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Platelet rich plasma </span></span></span></p>"
      },
      {
        "id": 61602,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Single donor platelets </span></span></span></p>"
      },
      {
        "id": 61603,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cryoprecipitate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">A 58-year-old man with a history of hemophilia A requires a blood product transfusion during a surgical procedure. </span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">ABO incompatibility is not seen with:</span></span></span></span></p>",
    "unique_key": "Q8641153",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619967,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D) Cryoprecipitate </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cryoprecipitate is prepared from <strong>FFP by cold precipitation </strong>and contains a<strong> high concentration </strong>of specific coagulation factors like <strong>fibrinogen, factor VIII, factor XIII, and von Willebrand factor. </strong>It has minimal <strong>plasma and ABO antigens</strong>, <strong>reducing the risk of ABO incompatibility reactions.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Fresh frozen plasma:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> FFP contains all<strong> coagulation factors</strong>, including soluble <strong>ABO antigens</strong>. <strong>ABO incompatibility </strong>can lead to <strong>hemolytic reactions</strong>; thus, it should be <strong>matched </strong>with the <strong>recipient&#39;s blood group</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Platelet-rich plasma:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> PRP is derived from <strong>whole blood and retains the ABO antigens</strong>. Transfusion with<strong> incompatible PRP </strong>can also lead to<strong> hemolytic reactions.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Single donor platelets:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Single donor platelets carry the<strong> donor&#39;s ABO antigens</strong>, and while the risk is <strong>lower compared to red cell transfusion, ABO compatibility </strong>is still preferred to minimize the risk of reaction.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">While <strong>ABO matching </strong>is ideal for all <strong>blood components</strong>, <strong>cryoprecipitate </strong>is the least likely to cause an<strong> ABO incompatibility reaction </strong>due to its<strong> low content of plasma </strong>and <strong>ABO antigens</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Wintrobes 12<sup>th</sup> /850</span></strong></span></span></p>",
    "correct_choice_id": 61603,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15418,
    "choices": [
      {
        "id": 61632,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolonged PTT </span></span></p>"
      },
      {
        "id": 61633,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolonged PT </span></span></p>"
      },
      {
        "id": 61634,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low platelet count </span></span></p>"
      },
      {
        "id": 61635,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abnormal BT </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">A 23-year-old male presents to the clinic with recurrent, spontaneous joint hemarthroses. Family history is significant for similar symptoms in his maternal uncles. Laboratory evaluation reveals a specific factor deficiency. Which laboratory finding is most consistent with a diagnosis of Hemophilia A? </span></span></span></span></span></p>",
    "unique_key": "Q7080398",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619969,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Prolonged PTT </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">PTT </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is prolonged by <strong>deficiency </strong>of factors <strong>XII, XI, IX, III, X, V, prothrombin and fibrinogen</strong></span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">and drugs like <strong>hep&shy;arin </strong></span>&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemophilia A </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">is characterized by the deficiency of <strong>factor 8 </strong>and decreased activity of intrinsic pathway. This is associated with prolongation of <strong>partial thromboplastin time</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Prolonged PTT:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> This is the correct answer. <strong>Hemophilia A </strong>is caused by a <strong>deficiency in factor VIII</strong>, which is part of the <strong>intrinsic coagulation pathway</strong>. The <strong>activated partial thromboplastin time (PTT) test </strong>evaluates the <strong>intrinsic and common coagulation pathways </strong>and will be <strong>prolonged in Hemophilia A.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Prolonged PT:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> The prothrombin time (PT) test evaluates the <strong>extrinsic and common pathways</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Low platelet count:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> Hemophilia A <strong>does not </strong>affect the <strong>platelet count</strong>; it is a <strong>coagulation factor deficiency </strong>and does not involve <strong>quantitative platelet defects.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Abnormal BT</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Bleeding time tests <strong>primary hemostasis</strong>, which includes <strong>platelet function</strong>. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Hemophilia A</strong>, a genetic disorder characterized by <strong>factor VIII deficiency </strong>leads to<strong> impaired </strong>function of the<strong> intrinsic coagulation pathway</strong>. This manifests clinically with a<strong> prolonged activated partial thromboplastin time (PTT) and a normal prothrombin time (PT) and bleeding time (BT).</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 668</span></strong></span></span></p>",
    "correct_choice_id": 61632,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 14726,
    "choices": [
      {
        "id": 58865,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">B cell</span></p>"
      },
      {
        "id": 58866,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">T-cells</span></p>"
      },
      {
        "id": 58867,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Plasma cells</span></p>"
      },
      {
        "id": 58868,
        "text": "<p><span style=\"font-size:12pt;\">Basophils</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">The biopsy of the small intestine from a patient presenting with gastrointestinal symptoms shows increased cells within the intra-epithelial layer of the mucosa. </span><span style=\"font-size:12.0pt;\">In the intra-epithelial region of the mucosa of intestine the predominant cell population is that of:</span></p>",
    "unique_key": "Q5450616",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619947,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) T-cells</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Intra-epithelial lymphocytes (IELs) </strong>are <strong>predominantly T cells</strong>, especially <strong>CD8+ T cells </strong>in the <strong>small intestine</strong>, which function in the <strong>immune response to pathogens </strong>and in maintaining<strong> epithelial integrity</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>B cells</strong> are a vital part of the <strong>adaptive immune system </strong>and are present in the <strong>gut-associated lymphoid tissue</strong>; however, they are <strong>not </strong>the <strong>predominant cell type in the intra-epithelial region</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option C.&nbsp;Plasma cells&nbsp;</strong>are found in the<strong> lamina propria </strong>where they produce<strong> antibodies, </strong>especially<strong> IgA</strong>, which is critical for <strong>mucosal immunity</strong>, but they are <strong>not the primary cell type in the intra-epithelial space</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Basophils </strong>are part of the<strong> innate immune system </strong>and are found in the blood; they are <strong>not </strong>typically located within the intra-epithelial layer of the intestinal mucosa.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">In the <strong>intra-epithelial region of the mucosa of the intestine</strong>, the predominant cell population is that of <strong>CD8+ T-cells</strong>, which are dispersed among the<strong> luminal epithelial cells.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Direct quote. \u2018<strong>IEL </strong>are a <strong>distinctive population of T cells </strong>dispersed among the <strong>luminal epithelial cells. </strong>Particular\u00adly in the <strong>small intestine, </strong>there is a predominance of<strong> CD 8+T cells.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>&nbsp;<u>Ref</u>: Mucosal Immunology Elsevier, 3rd/565</strong></span></p>",
    "correct_choice_id": 58866,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15398,
    "choices": [
      {
        "id": 61552,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Defect platelet function</span></p>"
      },
      {
        "id": 61553,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Reduced factor VIII in plasma</span></p>"
      },
      {
        "id": 61554,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Defective platelet adhesion</span></p>"
      },
      {
        "id": 61555,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">All of the above</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\">A 28-year-old female presents with easy bruising and prolonged bleeding after minor injuries. She has a family history of bleeding disorders. Which of the following is caused by VWF factor deficiency?</span></p>",
    "unique_key": "Q9710633",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619959,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\"><strong>Ans. D) All of the above</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Von Willebrand factor (VWF) deficiency </strong>can lead to several effects on the <strong>coagulation process:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Defect platelet function:</strong> <strong>True</strong>. VWF plays a crucial role in <strong>platelet adhesion by binding to platelets </strong>and stabilizing the interaction between <strong>platelets and the damaged blood vessel wall</strong>. Its <strong>reduced levels lead to reduced platelet functioning</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B. Reduced factor VIII in plasma:</strong> <strong>True</strong>. VWF serves as a <strong>carrier protein for factor VIII</strong>, protecting it from rapid <strong>clearance and degradation</strong>. Therefore, a deficiency in VWF can result in <strong>decreased levels of factor VIII </strong>in the plasma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Defective platelet adhesion</strong>:<strong> True</strong>. VWF is essential for the initial <strong>adhesion of platelets to the damaged blood vessel wall</strong>, facilitating the formation of a <strong>stable plug at the site of injury.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">So, the correct answer is (d) All of the above. <strong>Von Willebrand factor deficiency </strong>affects both<strong> platelet function and factor VIII levels in the plasma</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:12pt;\">VWF deficiency impairs <strong>platelet adhesion and aggregation </strong>at the site of <strong>vascular injury, </strong>and <strong>reduces the plasma level of factor VIII </strong>by<strong> decreasing its stability </strong>in circulation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup>/ 660</strong></span></p>",
    "correct_choice_id": 61555,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 13653,
    "choices": [
      {
        "id": 54573,
        "text": "<p><span style=\"font-size:12.0pt;\">Benzopyrene causes lung carcinoma</span></p>"
      },
      {
        "id": 54574,
        "text": "<p><span style=\"font-size:12.0pt;\">Allen test is used to asses chemical Mutagenicity</span></p>"
      },
      {
        "id": 54575,
        "text": "<p><span style=\"font-size:12.0pt;\">Indirect agents require Cytochrome P450 for conversion into carcinogen</span></p>"
      },
      {
        "id": 54576,
        "text": "<p><span style=\"font-size:12.0pt;\">Chemical carcinogen converts salmonella into histidine positive type</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the false statement:</span></p>",
    "unique_key": "Q2196307",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619978,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Allen test is used to asses chemical mutagenicity</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Allen test</strong>: The Allen test is used to assess <strong>collateral blood flow to the hands</strong>, generally in preparation for a procedure that has the <strong>potential to disrupt blood flow in either the radial or the ulnar artery</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The Ames test&nbsp;</strong>is a <strong>widely employed method </strong>to asses <strong>chemical mutagenicity </strong>using <strong>salmonella bacteria.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>&nbsp;<strong>Benzo[a]pyrene</strong>, are formed during the <strong>high-temperature </strong>combustion of<strong> tobacco in cigarettes </strong>and are implicated in the <strong>causation of lung cancer.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong>&nbsp;Indirect-acting carcinogens require <strong>metabolic </strong>conversion to become <strong>active carcinogens </strong>by using <strong>cytochrome P-450\u2013dependent monooxygenases</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>The<strong> Ames test </strong>uses <strong>several strains of the bacterium Salmonella typhimurium </strong>that carry <strong>mutations in genes </strong>involved in <strong>histidine synthesis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ames test </strong>checks the<strong> capability of the tested substance </strong>in creating <strong>mutations </strong>that result in a return to a <strong>\"prototrophic</strong>\" state, so that the<strong> cells can grow on a histidine-free medium.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: 1. Robbins and Cotran pathologic basis of disease 10th edition page: 322</strong></span></p>",
    "correct_choice_id": 54574,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15392,
    "choices": [
      {
        "id": 61528,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediate refrigeration to preserve factor viability </span></span></p>"
      },
      {
        "id": 61529,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platelet-rich plasma is essential </span></span></p>"
      },
      {
        "id": 61530,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Done within 2 hours </span></span></p>"
      },
      {
        "id": 61531,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activated with kaolin </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">True about prothrombin time to:</span></span></span></p>",
    "unique_key": "Q8254468",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619954,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Done within 2 hours </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Done within 2 hours:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> <strong>PT testing </strong>should be performed within a <strong>specified time from sample collection</strong>, often <strong>within 2 hours</strong>, to ensure the <strong>viability of the coagulation factors</strong>, especially the <strong>labile factors V and VIII, </strong>which can deteriorate over time at room temperature.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. Immediate refrigeration to preserve factor viability:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> While it&#39;s true that certain <strong>coagulation factors </strong>are <strong>temperature sensitive</strong>, <strong>prothrombin time </strong>(PT) <strong>testing </strong>typically requires the sample to be <strong>kept at room temperature </strong>to <strong>prevent the cold activation of factors </strong>and potential precipitation of fibrinogen. Immediate refrigeration is not required for PT.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. Platelet-rich plasma is essential:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> <strong>PT </strong>is actually <strong>performed </strong>on <strong>platelet-poor plasma</strong>, not platelet-rich plasma. The presence of platelets can affect the test results by providing phospholipid surfaces that could artificially shorten the clotting time.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. Activated with kaolin:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> <strong>PT </strong>is <strong>not activated with kaolin</strong>. Instead, <strong>thromboplastin </strong>(a combination of tissue factor and phospholipids) is used to <strong>activate the extrinsic pathway of coagulation</strong>. Kaolin is used as an activator in the activated partial thromboplastin time (aPTT) test, which evaluates the intrinsic pathway.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">The <strong>PT test </strong>must be <strong>done on platelet-poor plasma </strong>and usually <strong>within 2 hours of sample collection </strong>to ensure <strong>accurate results</strong>, using <strong>thromboplastin for activation. </strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/10/picture1_R5zNr7B.jpg\" style=\"height:270px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Dacie and Lewis practical hematology 10th/392, 398</span></strong></span></span></span></p>",
    "correct_choice_id": 61530,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15400,
    "choices": [
      {
        "id": 61560,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most of the patients respond to immunosuppressive doses of glucocorticoids</span></span></p>"
      },
      {
        "id": 61561,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Relapse is rare </span></span></p>"
      },
      {
        "id": 61562,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Splenectomy is the treatment of choice for relapse </span></span></p>"
      },
      {
        "id": 61563,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minority have refractory forms of ITP and difficult to treat </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">A 32-year-old woman with a diagnosis of chronic immune thrombocytopenic purpura (ITP) returns for a follow-up visit. She previously responded well to a course of glucocorticoids but presented again with petechiae and a platelet count of 25,000/&mu;L. She has no splenomegaly on examination. </span></span>All the following statements are correct about treatment in chronic immune thrombocytopenic purpura except:</span></span></span></p>",
    "unique_key": "Q4434540",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619961,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B) Relapse is rare </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is <strong>incorrect </strong>because <strong>relapses after initial treatment with glucocorticoids </strong>are common in<strong> chronic ITP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. While initial treatment with<strong> glucocorticoids </strong>can be effective, many patients with <strong>chronic ITP </strong>may <strong>not </strong>achieve sustained <strong>remission and can experience relapses.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Splenectomy </strong>is typically considered <strong>after glucocorticoids and other medical therapies have failed</strong>, making it not a first-line treatment, but rather a treatment for <strong>relapsed or refractory cases</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Some patients with<strong> chronic ITP </strong>do not respond to <strong>conventional therapies or relapse following initial therapy</strong>, which may suggest a<strong> refractory form of the disease</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Direct quote&hellip;. &ldquo;Almost all patients<strong> respond to gluco&shy;corticoids </strong>(which inhibit phagocyte function), but<strong> many eventually relapse</strong>.&rdquo; </span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In individuals with <strong>severe thrombocytopenia, sple&shy;nectomy normalizes</strong> the <strong>platelet counts. </strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Immunomodulatory agents</strong> such as <strong>intravenous immunoglobulin or anti-CD20 antibody (rituximab) </strong>are often effective in patients who <strong>relapse after splenectomy </strong>or for whom <strong>splenectomy is contraindicated. </strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 659</span></strong></span></span></span></p>",
    "correct_choice_id": 61561,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15346,
    "choices": [
      {
        "id": 61344,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Burkitt&rsquo;s lymphoma </span></span></span></p>"
      },
      {
        "id": 61345,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mycosis fungoides </span></span></span></p>"
      },
      {
        "id": 61346,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mantle cell lymphoma</span></span></span></p>"
      },
      {
        "id": 61347,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular cell lymphoma </span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are B cell lymphomas except:</span></span></span></p>",
    "unique_key": "Q5018277",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619987,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Mycosis fungoides </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mycosis fungoides </strong>is <strong>not a B-cell lymphoma</strong>; it is a type of<strong> cutaneous T-cell lymphoma. </strong>It primarily involves the <strong>skin and represents a neoplastic proliferation of mature T-helper cells</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Burkitt&#39;s lymphoma </strong>is indeed a<strong> B-cell lymphoma. </strong>It is an aggressive form of<strong> non-Hodgkin lymphoma </strong>that is associated with the <strong>Epstein-Barr virus (EBV) </strong>and characterized by the <strong>translocation </strong>involving the <strong>MYC gene</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Mantle cell lymphoma </strong>is a<strong> B-cell lymphoma </strong>characterized by the<strong> proliferation of malignant B-cells </strong>with characteristic involvement of the <strong>mantle zone in lymphoid follicles</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Follicular lymphoma </strong>is a<strong> B-cell lymphoma</strong>. It is a <strong>slow-growing, indolent lymphoma </strong>characterized by the proliferation of <strong>abnormal B-cells </strong>within the lymph nodes.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mycosis fungoides </strong>is a type of<strong> cutaneous T-cell lymphoma </strong>and not a B-cell lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"color:black\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 606)</span></span></em></strong></span></span></em></strong></span></span></p>",
    "correct_choice_id": 61345,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15399,
    "choices": [
      {
        "id": 61556,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bernard Soulier syndrome </span></span></p>"
      },
      {
        "id": 61557,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glanzmann disease </span></span></p>"
      },
      {
        "id": 61558,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Von willebrand disease </span></span></p>"
      },
      {
        "id": 61559,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gray platelet syndrome </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old male presents with a history of recurrent nosebleeds, easy bruising, and prolonged bleeding after minor injuries. He has a deficiency of glycoprotein IIb-IIIa complex. </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycoprotein IIb-IIIa complex is deficient in which of the following conditions? </span></span></span></p>",
    "unique_key": "Q2348333",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619960,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B) Glanzmann disease </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\">&nbsp;&nbsp; </span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glanzmann disease </strong>is a <strong>congenital platelet disorder </strong>characterized by a deficiency or dysfunction of the <strong>glycoprotein IIb-IIIa complex </strong>on the surface of platelets. This complex is essential for <strong>platelet aggregation by binding fibrinogen </strong>and facilitating <strong>platelet-platelet interaction</strong>. In Glanzmann disease, i<strong>mpaired platelet aggregation </strong>leads to a tendency for <strong>prolonged bleeding.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Bernard Soulier syndrome</strong> is associated with a deficiency of<strong> glycoprotein Ib-IX-V complex</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>von Willebrand disease</strong> is associated with deficiencies or dysfunction of <strong>von Willebrand factor</strong>, not the glycoprotein IIb-IIIa complex.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Gray platelet syndrome</strong> is a <strong>rare platelet disorder </strong>characterized by <strong>grayish platelets and a deficiency of alpha-granules.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong>&nbsp;</strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycoprotein IIb-IIIa complex </strong>is deficient in <strong>Glanzmann&rsquo;s disease</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> /120</span></strong></span></span></span></p>",
    "correct_choice_id": 61557,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15403,
    "choices": [
      {
        "id": 61572,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lack of H, A and B antigen on RBCs </span></span></p>"
      },
      {
        "id": 61573,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lack of H, A and B substance in saliva </span></span></p>"
      },
      {
        "id": 61574,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lack of antigens of several blood group systems </span></span></p>"
      },
      {
        "id": 61575,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H, A and B antibody will always be present in se&shy;rum </span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">A 30-year-old male requires a blood transfusion after a severe car accident. He is known to have the Bombay phenotype. Prior to the transfusion, his blood sample is sent to the laboratory for compatibility testing. Based on his blood group, which of the following statements is incorrect?</span></span> </span></span></span></p>",
    "unique_key": "Q3552180",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619962,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Lack of antigens of several blood group systems</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option C: </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">People with<strong> Bombay phenotype (rarest blood </strong>group in the <strong>world) </strong>express <strong>no A, B or H antigens on the red blood cells. </strong>These are <strong>homozygous </strong>for the silent <strong>h allele </strong>(being represented h). So, these antigens are<strong> not present </strong>in the <strong>saliva </strong>also. As the <strong>antigens are not expressed, </strong>so, the<strong> H, A and B antibody </strong>will always be present in<strong> serum</strong>. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">ABO antigens are present not only on the<strong> red blood cells </strong>abut also on the<strong> other blood cells</strong>, in most body fluids (<strong>except CSF</strong>),<strong> cell membrane of tissues </strong>such as <strong>intestine, urothelium and vascular endothelium</strong>. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">He lacks antigens from multiple blood group systems:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> This statement is<strong> incorrect</strong>. Individuals with the <strong>Bombay phenotype </strong>only lack <strong>antigens </strong>in the <strong>ABO blood group system </strong>specifically related to <strong>A, B, and H antigens. </strong>They<strong> do not lack antigens </strong>from other <strong>blood group systems</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option A. His red blood cells lack H, A, and B antigens:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> This statement is<strong> correct. </strong>Individuals with the Bombay blood group<strong> do not express A, B, or H antigens on their red blood cells </strong>due to a homozygous mutation in the H gene <strong>(hh genotype).</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option B. His saliva does not contain H, A, and B substances:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> This statement is<strong> correct. </strong>The lack of H antigen also affects the presence of these <strong>antigens in body fluids</strong>, including<strong> saliva</strong>, because the <strong>H antigen is a precursor for A and B antigen synthesis.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Option D. His serum contains antibodies against H, A, and B antigens:</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\"> This statement is <strong>correct</strong>. Because individuals with the Bombay phenotype<strong> do not express A, B, or H antigens on their red blood cells</strong>, they will form<strong> antibodies against </strong>these antigens if <strong>exposed.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></u></strong>&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0d0d0d\">Individuals with the Bombay phenotype lack A, B, and H antigens on their red blood cells and in their saliva, and their serum contains antibodies against these antigens. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Book Antiqua&quot;,serif\"><span style=\"color:black\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Wintrobe&rsquo;s hematology 12th/635-6</span></strong></span></span></span></p>",
    "correct_choice_id": 61574,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 15353,
    "choices": [
      {
        "id": 61372,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte predominant </span></span></span></p>"
      },
      {
        "id": 61373,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nodular sclerosis</span></span></span></p>"
      },
      {
        "id": 61374,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mixed cellularity </span></span></span></p>"
      },
      {
        "id": 61375,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte depleted </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old male presents with painless enlargement of a cervical lymph node. Excisional biopsy reveals a subtype of Hodgkin&rsquo;s disease, which is histogenetically distinct from all the other subtypes. Which of the following is the likely diagnosis? </span></span></span></p>",
    "unique_key": "Q1146916",
    "question_audio": null,
    "question_video": null,
    "map_id": 34619991,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Lymphocyte predominant </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphocyte Predominant</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This subtype is characterized by a <strong>nodular pattern </strong>with a predominance of<strong> lymphocytes </strong>and the presence of<strong> popcorn cells (Lacunar cells). </strong>Popcorn cells are<strong> large, atypical mononuclear or multinucleated cells</strong>. This subtype is generally associated with an<strong> excellent prognosis</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Nodular Sclerosis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Nodular sclerosis is the <strong>most common </strong>subtype of <strong>Hodgkin&#39;s lymphoma in the world. </strong>It is characterized by the presence of <strong>collagen bands </strong>dividing the <strong>lymph node architecture into nodules</strong>.<strong> Reed-Sternberg cells</strong>, the hallmark cells of <strong>Hodgkin&#39;s lymphoma, </strong>are found in lacunar spaces. This subtype often affects<strong> young adults </strong>and typically presents with <strong>mediastinal involvement</strong>. It has a favorable prognosis.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Mixed Cellularity:</strong> This subtype is characterized by a<strong> mixed inflammatory infiltrate</strong>, including <strong>eosinophils, plasma cells, and histiocytes</strong>, along with<strong> Reed-Sternberg cells</strong>. It is often associated with an<strong> advanced stage of the disease </strong>and has a less favorable prognosis compared to nodular sclerosis.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lymphocyte Depleted</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This<strong> subtype </strong>is characterized by a<strong> scarcity of lymphocytes </strong>and <strong>an abundance of Reed-Sternberg cells</strong>. It is associated<strong> with </strong>an <strong>advanced stage of the disease </strong>and is often seen in <strong>immunocompromised individuals</strong>. Lymphocyte-depleted Hodgkin&#39;s lymphoma has a <strong>less favorable prognosis</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lymphocyte predominant Hodgkin&rsquo;s disease </strong>is<strong> histogenetically distinct </strong>from other <strong>subtypes, </strong>characterized by a <strong>nodular pattern </strong>with a <strong>predominance of lymphocytes </strong>and the presence of <strong>popcorn cells</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Ref: Robbins 10<sup>th</sup> 613)</span></span></em></strong></p>",
    "correct_choice_id": 61372,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = '00273 Mid Day Module (Pathology-3)';
        const quizFilename = '00273-mid-day-module-pathology-3-ca6ccbad.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Mid Day Module"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>